Your browser is no longer supported. Please, upgrade your browser.
Settings
AMGN Amgen Inc. daily Stock Chart
AMGN [NASD]
Amgen Inc.
IndexS&P 500 P/E15.63 EPS (ttm)10.26 Insider Own0.10% Shs Outstand736.00M Perf Week-0.74%
Market Cap118.06B Forward P/E12.59 EPS next Y12.74 Insider Trans0.00% Shs Float734.84M Perf Month-4.20%
Income7.72B PEG2.41 EPS next Q3.00 Inst Own80.60% Short Float1.20% Perf Quarter4.43%
Sales22.99B P/S5.14 EPS this Y13.10% Inst Trans0.03% Short Ratio2.35 Perf Half Y0.95%
Book/sh40.59 P/B3.95 EPS next Y3.29% ROA10.10% Target Price185.23 Perf Year0.17%
Cash/sh51.75 P/C3.10 EPS next 5Y6.49% ROE25.90% 52W Range131.83 - 184.21 Perf YTD10.47%
Dividend4.60 P/FCF18.11 EPS past 5Y20.50% ROI13.00% 52W High-12.92% Beta1.28
Dividend %2.87% Quick Ratio3.90 Sales past 5Y8.10% Gross Margin81.90% 52W Low21.68% ATR2.43
Employees19200 Current Ratio4.10 Sales Q/Q7.70% Oper. Margin42.60% RSI (14)33.49 Volatility1.08% 1.23%
OptionableYes Debt/Eq1.16 EPS Q/Q10.50% Profit Margin33.60% Rel Volume0.77 Prev Close162.04
ShortableYes LT Debt/Eq1.01 EarningsApr 26 AMC Payout38.70% Avg Volume3.75M Price160.41
Recom2.40 SMA20-1.78% SMA50-5.57% SMA200-0.11% Volume2,894,619 Change-1.01%
Apr-05-17Downgrade Jefferies Buy → Hold
Mar-09-17Initiated UBS Neutral $185
Feb-01-17Upgrade BofA/Merrill Neutral → Buy
Dec-20-16Downgrade Credit Suisse Outperform → Neutral
Dec-13-16Initiated Oppenheimer Outperform
Nov-08-16Initiated Mizuho Buy $164
Aug-26-16Initiated Gabelli & Co Hold
Jun-29-16Initiated Bernstein Mkt Perform
Feb-25-16Initiated Citigroup Neutral $165
Feb-08-16Reiterated Argus Buy $202 → $185
Jan-20-16Initiated Credit Suisse Outperform $205
Dec-15-15Upgrade Morgan Stanley Equal-Weight → Overweight
Dec-04-15Initiated Wells Fargo Market Perform
Oct-29-15Reiterated UBS Buy $168 → $180
Sep-01-15Initiated Raymond James Mkt Perform
Jul-31-15Reiterated RBC Capital Mkts Outperform $185 → $190
Jul-31-15Reiterated Deutsche Bank Buy $192 → $195
Jul-31-15Reiterated Barclays Equal Weight $180 → $185
May-28-15Reiterated Deutsche Bank Buy $200 → $192
Apr-22-15Reiterated UBS Buy $175 → $185
Apr-23-17 06:55PM  Johnson & Johnson's Weak Pharma Revenue Could Spell Doom for Rest of Sector TheStreet.com
02:03PM  Read This Before You Buy Biotech Stocks Motley Fool
10:25AM  Alphabet, Amazon, AT&T and Other Key Earnings Coming This Week 24/7 Wall St.
Apr-21-17 04:15PM  Amgen Trumps Regeneron, Sanofi In Cholesterol Drug Sales Investor's Business Daily
04:00PM  Amgen Announces Webcast Of 2017 First Quarter Financial Results PR Newswire
11:18AM  Amgen (AMGN) to Report Q1 Earnings: Will it Beat Again? Zacks
Apr-20-17 05:53PM  What to expect from biotech CNBC Videos
02:55PM  Celgene to expand in Cambridge, taking former Amgen space American City Business Journals
10:16AM  What's in Store for Biogen (BIIB) this Earnings Season? Zacks
09:31AM  Sanofi Genzyme hit with patent lawsuit over new eczema drug American City Business Journals
Apr-19-17 04:17PM  Is J&J's Pharma Sales Slowdown a Warning for Other Players? Zacks
Apr-18-17 04:00PM  Amgen Launches Neulasta® (pegfilgrastim) Onpro® NARRATIVES PR Newswire
09:30AM  The Zacks Analyst Blog Highlights: Alphabet, Amgen, Lowe's, Bristol-Myers and Priceline Zacks
Apr-17-17 05:43PM  Billion dollar drug bust CNBC Videos
04:43PM  Top Research Reports for Alphabet, Amgen & Lowe's Zacks
01:03PM  5 Major Drug Stocks Likely to Beat Q1 Earnings Estimates Zacks
Apr-15-17 12:23AM  [$$] As Drug Prices Fall, These Stocks Could Rise Barrons.com
Apr-13-17 04:18PM  The Hot Stock: Alexion Pharmaceuticals Climbs 3.3% Barrons.com
Apr-12-17 03:46PM  Amgen's Offering a Money Back Guarantee for Repatha. Will It Be Enough? Motley Fool
12:51PM  How These Biotechs Could Save The Drug Sector In Q1 Or Not Investor's Business Daily
10:13AM  Don't Get Your Hopes Up For Biotech's Q1 Earnings Barrons.com
09:10AM  Short Sellers Back Off Major Biotechs 24/7 Wall St.
06:00AM  First Quarter Earnings Preview: Biotech Heavyweights Investopedia
Apr-11-17 03:03PM  3 Big Drugmakers Most Likely to Buy Incyte Motley Fool
08:08AM  The 3 Top Dividend Stocks in the Healthcare Sector Motley Fool
Apr-10-17 09:49AM  10 Reasons Amgen Could Be the World's Most Perfect Stock Motley Fool
03:40AM  Why Big Pharma Is Turning to Biological Drugs MarketWatch
Apr-09-17 04:16PM  Amgen Files Marketing Applications to Expand Xgeva's Use to US and EU MM Paitents GuruFocus.com
Apr-08-17 04:11PM  3 Big Biotech Stocks With Big-Time Catalysts Motley Fool
Apr-07-17 02:00PM  Earnings Preview: Biotechnology Looks Healthy Barrons.com
01:38PM  Analysts Release New Health Care Stock Ratings GuruFocus.com
01:34PM  Why Roche's New Drug Is Bad News For Biogen Barrons.com
Apr-06-17 03:31PM  Iceland's genetic goldmine, and the man behind it CNBC
03:30PM  Iceland: Genealogists' heaven CNBC Videos
01:08PM  Sanofi May Now Have Moved Past Its Most Challenging Period, Analyst Initiates At Buy Benzinga
08:03AM  This Is Why Radius Health Inc. Tumbled 8.6% in March Motley Fool
Apr-05-17 04:21PM  Amgen Payer Pushback Likely To Sting Amid Battle With Regeneron, Sanofi Investor's Business Daily
04:20PM  Citigroup, Wells Fargo Upgraded; Tenet A Buy; Teradyne PT Hiked Investor's Business Daily
12:06PM  Amgen Receives Hold Rating at Jefferies -- Jim Cramer Says It Could Be a Battleground TheStreet.com
11:20AM  Amgen Files for Xgeva Label Expansion, To Include Myeloma Zacks
09:53AM  Cramer's Stop Trading: Amgen downgrade CNBC Videos
08:59AM  Biotech Stock Roundup: Acorda Down on Court Ruling, Patent Challenge for CELG Drug Zacks
04:00AM  Why Is Amgen (AMGN) Up 12.9% Since the Last Earnings Report? Zacks
Apr-04-17 11:12AM  As Biotech Roars Back, Amgen Remains Dirt Cheap TheStreet.com
09:22AM  What's Next for Amgen's Repatha? Motley Fool
09:00AM  Amgen Submits Applications In The US And Europe To Expand Current Indication For XGEVA® (denosumab) To Include Patients With Multiple Myeloma PR Newswire
08:03AM  The No. 1 Dividend Grower For 2017 (From 50 Elite Finalists)
08:03AM  Amgen Offers A Money-Back Guarantee For Its Cholesterol Drug Repatha
Apr-03-17 03:10PM  Amgen will move 100 workers to San Francisco, Cambridge as part of restructuring at bizjournals.com
11:00AM  Sarepta chief hands over CMO role to former Regeneron exec at bizjournals.com
07:06AM  Kite Pharma Completes Filing for CAR-T Therapy with FDA
Apr-02-17 03:02PM  Healthcare Winners and Losers Following the AHCA's Failure at Motley Fool
Apr-01-17 11:42AM  Better Buy: Celgene Corporation vs. Amgen Inc. at Motley Fool
11:30AM  Amgen And UCB Report New Data At ENDO 2017 Examining The Option Of A Second Course Of Treatment With EVENITY (romosozumab) PR Newswire
Mar-31-17 03:36PM  FDA Grants Amgen Priority Review for Blincyto sBLA
10:36AM  Novartis Expects to Launch 5 Key Biosimilars by 2020
09:43AM  Can Vertex Keep Climbing? at Barrons.com
09:00AM  Amgen To Highlight New Preclinical Data At The American Association For Cancer Research (AACR) Annual Meeting PR Newswire
Mar-30-17 04:20PM  The 3 Best Cholesterol Drug Stocks to Buy in 2017 at Motley Fool
09:46AM  Amgen's Leukemia Drug Accepted for Priority Review by FDA
09:46AM  Amgen's Leukemia Drug Accepted for Priority Review by FDA at Investopedia
09:22AM  Amgen's Blincyto sBLA Secures FDA Priority Review at Investopedia
06:00AM  7 Dividends That Have Doubled Quickly at Motley Fool
Mar-29-17 04:07PM  FDA Grants Priority Review For Amgen's BLINCYTO® (blinatumomab) Supplemental Biologics License Application PR Newswire
04:03PM  Journal Of Clinical Oncology Publishes Data On BLINCYTO® (Blinatumomab) In High-Risk Patients With Philadelphia Chromosome-Positive B-Cell Precursor Acute Lymphoblastic Leukemia PR Newswire
03:42PM  3 Drugmakers With Boatloads of Cash to Spend at Motley Fool
11:55AM  Sanofi Genzyme files preemptive legal strike to protect eczema drug at bizjournals.com
10:36AM  Cosentyx Enjoys Solid Demand as Psoriasis Therapy in Europe
09:06AM  Which Segments Will Drive the Most Growth for Novartiss Cosentyx?
09:06AM  Performance of Key Pharmaceuticals Products for GlaxoSmithKline
08:15AM  Biotech Stock Roundup: Regeneron, Tesaro Drugs Approved, Vertex Scores Big in Study
Mar-28-17 05:30PM  Amgen to move or cut nearly 500 jobs in Thousand Oaks at bizjournals.com
09:00AM  Amgen Awards Three Golden Tickets for LabCentral Residency PR Newswire
08:57AM  Cousins (CUZ) Inks Lease with Amgen at Corporate Center
Mar-27-17 08:24PM  The 'Fearless Girl' Statue Isn't a Symbol, It Is an Advertisement
05:49PM  Amgen's Humira Biosimilar Approved in Europe
04:05PM  Could It Be Time to Buy US Domestic Moats?
10:30AM  Short Interest Pulls Back in Major Biotechs
09:08AM  Mercks Keytruda Saw Impressive Growth in 2016
08:42AM  5 Stocks With Ridiculously Fast-Growing Dividends at Motley Fool
Mar-24-17 04:41PM  Why You're Smart to Buy Jazz Pharmaceuticals plc at Motley Fool
03:11PM  Google life sciences spinoff soaks up huge space (video) at bizjournals.com
01:44PM  Sanofi Could Acquire This Biotech, But Is $1 Billion Too Low?
11:27AM  Amgen's (AMGN) Humira Biosimilar Receives Approval in EU
09:30AM  The Zacks Analyst Blog Highlights: Berkshire Hathaway, Amgen, Walgreens Boots Alliance, General Electric and Carnival
05:24AM  Amgen Secures EU Approval for Anti-Inflammatory Drug at Investopedia
Mar-23-17 04:00PM  European Commission Approves AMGEVITA (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases PR Newswire
03:40PM  Stock Research Reports for Amgen, Berkshire & Walgreens
02:07PM  Regeneron, Sanofi Look To Crush Amgen, And Rivals Say They Can
10:57AM  Biotechs Back in the Doghouse After Failed Rally at Investopedia
09:00AM  How This Company Is Taking on Amgen at Motley Fool
Mar-22-17 03:21PM  Biotech giant plans $25M Tampa investment, 450 jobs at bizjournals.com
11:25AM  Health ETF Wobbles As Vote On Bill To Replace ObamaCare Nears; Gold Gains
09:30AM  Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen
08:33AM  Biotech Stock Roundup: Amgen Down on Repatha Data, Nektar Surges on Pain Results
Mar-21-17 04:54PM  Sanofi and Regeneron Sue Amgen over Eczema Drug at Investopedia
12:49PM  4 Health Care Charts Signaling Buys: Pfizer, Amgen Included
12:33PM  Sanofi, Regeneron sue Amgen to protect eczema drug from patent claims
11:00AM  ONCYF: Oncolytic Viruses Emerging as Effective Cancer Treatment
09:25AM  3 Biotech Stocks That Are Broker Favorites
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of illness in the areas of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company's products include Evenity to treat osteoporosis in postmenopausal women; Prolia to treat postmenopausal women with osteoporosis; Xgeva for the prevention of skeletal-related events; Repatha to treat coronary artery diseases; Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Parsabiv to treat secondary hyperparathyroidism (sHPT); and Erenumab for the prevention of chronic migraine. Its products also comprise Blincyto to treat patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia; Kyprolis, a proteasome inhibitor to treat patients with multiple myeloma and small-cell lung cancer; Nplate, a thrombopoietic compound; AMJEVITA to treat psoriatic arthritis and polyarticular juvenile idiopathic arthritis, as well as ankylosing spondylitis and moderate-to-severe rheumatoid arthritis; ABP 215 for biosimilar candidates; and ABP 980 to treat human epidermal growth factor receptor 2-positive early breast cancer. The company's other marketed products include Neulasta, a pegylated protein to treat cancer patients; Aranesp to treat anemia; Sensipar/Mimpara products for use to treat sHPT in chronic kidney disease; EPOGEN to treat a lower-than-normal number of red blood cells; NEUPOGEN, a recombinant-methionyl human granulocyte colony-stimulating factor; and IMLYGIC to treat various cancer cells. It serves pharmaceutical wholesale distributors; and physicians or their clinics, dialysis centers, hospitals, and pharmacies, as well as consumers. The company has collaborative agreements with Pfizer Inc.; UCB; and Bayer HealthCare Pharmaceuticals Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
de Carbonnel FrancoisDirectorSep 09Option Exercise71.645,000358,20021,171Sep 13 06:21 PM
Such Annette LouiseVP, Finance and CAOAug 02Sale174.593,000523,7587,183Aug 03 08:14 PM
Balachandran MadhavanEVP, OperationsMay 04Sale154.1230,0004,623,62455,996May 05 08:16 PM
BALTIMORE DAVIDDirectorApr 29Sale157.213,312520,68432,350May 03 07:12 PM
UNP Union Pacific Corporation daily Stock Chart
UNP [NYSE]
Union Pacific Corporation
IndexS&P 500 P/E21.35 EPS (ttm)5.07 Insider Own0.20% Shs Outstand819.20M Perf Week3.34%
Market Cap88.70B Forward P/E17.08 EPS next Y6.34 Insider Trans-2.72% Shs Float810.28M Perf Month4.06%
Income4.23B PEG1.89 EPS next Q1.23 Inst Own81.50% Short Float1.36% Perf Quarter0.27%
Sales19.94B P/S4.45 EPS this Y-7.70% Inst Trans0.14% Short Ratio3.03 Perf Half Y12.80%
Book/sh24.33 P/B4.45 EPS next Y12.41% ROA7.60% Target Price114.96 Perf Year27.03%
Cash/sh1.63 P/C66.34 EPS next 5Y11.27% ROE20.90% 52W Range78.76 - 110.75 Perf YTD5.03%
Dividend2.42 P/FCF41.43 EPS past 5Y8.60% ROI13.60% 52W High-2.23% Beta0.78
Dividend %2.23% Quick Ratio0.80 Sales past 5Y0.40% Gross Margin81.20% 52W Low37.48% ATR1.75
Employees42919 Current Ratio1.00 Sales Q/Q-0.80% Oper. Margin36.50% RSI (14)58.70 Volatility1.42% 1.65%
OptionableYes Debt/Eq0.75 EPS Q/Q6.30% Profit Margin21.20% Rel Volume0.86 Prev Close107.90
ShortableYes LT Debt/Eq0.71 EarningsApr 27 BMO Payout43.20% Avg Volume3.64M Price108.28
Recom2.30 SMA202.06% SMA501.42% SMA2009.17% Volume3,140,472 Change0.35%
Mar-14-17Initiated Wells Fargo Market Perform
Jan-20-17Reiterated RBC Capital Mkts Sector Perform $111 → $115
Jan-20-17Reiterated Cowen Market Perform $98 → $109
Jan-18-17Initiated Buckingham Research Neutral
Jan-09-17Upgrade Barclays Equal Weight → Overweight $104 → $122
Nov-02-16Initiated Deutsche Bank Buy $110
Oct-24-16Initiated Seaport Global Securities Buy $100
Oct-21-16Downgrade RBC Capital Mkts Outperform → Sector Perform $107 → $98
Oct-20-16Downgrade Cowen Outperform → Market Perform $99 → $91
Jul-20-16Downgrade Deutsche Bank Buy → Hold $94
Jun-03-16Upgrade Morgan Stanley Equal-Weight → Overweight $90
May-19-16Initiated Credit Agricole Sell
Apr-22-16Reiterated RBC Capital Mkts Outperform $90 → $95
Apr-18-16Downgrade UBS Buy → Neutral $89 → $88
Feb-23-16Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-22-16Upgrade BofA/Merrill Neutral → Buy
Jan-25-16Reiterated Argus Buy $110 → $80
Jan-22-16Reiterated Stifel Buy $95 → $78
Jan-22-16Reiterated RBC Capital Mkts Outperform $93 → $82
Jan-22-16Reiterated Deutsche Bank Buy $93 → $87
Apr-21-17 04:52PM  Is the Railroad Industry Out of the Woods Yet? Zacks
02:35PM  Union Pacific: Behind the Freight Volume Rise in Week 15 Market Realist
01:05PM  Norfolk Southern: Commodities That Fueled Volumes in Week 15 Market Realist
12:54PM  Can Railroads Prosper Under the Trump Administration? Zacks
11:29AM  Kansas City Southern (KSU) Q1 Earnings In Line, Sales Beat Zacks
10:37AM  Will Union Pacific Beat Analysts Estimated Earnings in 1Q17? Market Realist
09:10AM  Union Pacific Corp. breached its 50 day moving average in a Bullish Manner : UNP-US : April 21, 2017 Capital Cube
09:07AM  Union Pacifics Operating Margin Battle: What the Analysts Think Market Realist
07:37AM  Can Union Pacifics 1Q17 Revenue Exceed Analysts Expectations? Market Realist
Apr-20-17 05:03PM  Inside Union Pacifics Stock Performance Ahead of Its 1Q17 Earnings Market Realist
04:23PM  CSX Hauls Rail Stocks Higher: These 3 Are Near Buy Points Investor's Business Daily
10:49AM  Union Pacific's Rally Is on the Right Track TheStreet.com
10:38AM  Union Pacific Corporation Invites You to Join Its 1st Quarter 2017 Earnings Release Broadcast PR Newswire
Apr-19-17 10:31AM  Zacks Industry Outlook Highlights: CSX, Canadian Pacific Railway, Norfolk Southern, Union Pacific and Kansas City Southern Zacks
07:37AM  BNSF Railway: Week 14 Saw a Double-Digit Volume Rise Market Realist
Apr-18-17 05:35PM  Union Pacific: Unloading Freight Volumes in Week 14 of 2017 Market Realist
04:58PM  Railroad Stock Industry Outlook - April 2017 Zacks
04:05PM  Norfolk Southern: What Drove Freight Volumes in Week 14? Market Realist
02:15PM  Canadian Pacific Railway: Overall Freight Traffic in Week 14 Market Realist
02:15PM  Union Pacific: A Look at Its Intermodal Volumes in Week 14 Market Realist
Apr-13-17 09:07AM  Exploring the Rationale behind the Knight-Swift Deal Market Realist
07:00AM  Are We Headed for a Bear Market? These 4 Charts Say No. TheStreet.com
Apr-12-17 05:35PM  Exploring the Deal Between Swift and Knight Transportation Market Realist
01:37PM  If You Are A Union Pacific Shareholder, You Should Read This Forbes
01:32PM  Union Pacific Corp. Value Analysis (NYSE:UNP) : April 12, 2017 Capital Cube
09:06AM  Canadian Pacific: How Its Freight Volume Compared with Its Peers Market Realist
Apr-11-17 10:37AM  Why BNSF Railway Posted a Robust Rise in Its Week 13 Freight Volumes Market Realist
09:07AM  Is Union Pacific Lagging behind BNSF in Intermodal Growth? Market Realist
08:30AM  Union Pacific Corp. breached its 50 day moving average in a Bullish Manner : UNP-US : April 11, 2017 Capital Cube
07:37AM  Did Union Pacific See Growth in Freight Volumes in the 13th Week of 2017? Market Realist
Apr-10-17 05:05PM  Norfolk Southern: Why Freight Volumes Rose in Week 13 of 2017 Market Realist
Apr-07-17 11:04AM  [$$] Two Rails With Opportunity Barrons.com
Apr-06-17 09:50AM  Report: Union Pacific fared worst in oil-train route inspections American City Business Journals
Apr-05-17 03:20PM  APNewsBreak: Thousands of defects found on oil train routes Associated Press
07:35AM  Canadian Pacific: How Its Carloads Compare with Canadian National Market Realist
Apr-03-17 12:34PM  Union Pacific is Safest US Railroad Second Year in a Row PR Newswire
09:07AM  Were Union Pacifics Intermodal Volumes in Line in the 12th Week? Market Realist
07:37AM  Why Union Pacifics Carloads Rose in the 12th Week Market Realist
Mar-31-17 05:35PM  Unloading Norfolk Southerns Carloads in Week 12 Market Realist
Mar-30-17 05:08PM  What Infrastructure Spending Cuts Mean for Freight Companies Market Realist
09:00AM  Union Pacific Corporation Invites You to Join Its 1st Quarter 2017 Earnings Release Broadcast PR Newswire
Mar-29-17 11:26AM  Union Pacific Corp. : UNP-US: Dividend Analysis : February 28th, 2017 (record date) : By the numbers : March 29, 2017 Capital Cube
10:36AM  A Sharp Rise in Trailer Volumes Boosted KSUs Intermodal Traffic
09:06AM  Did Coal Volumes Push Up BNSF Railways Carloads in Week 11?
08:54AM  Would you pay $6 million for this East Bay home with its own star observatory? at bizjournals.com
07:37AM  Did Coal Boost Canadian Pacifics Carloads in Week 11?
07:37AM  Understanding the Direction of UNPs Week 11 Intermodal Volumes
12:23AM  [$$] Hiring Veterans Is Easy. Keeping Them Is Hard at The Wall Street Journal
Mar-28-17 03:35PM  Which Commodities Drove Union Pacifics Carloads in Week 11?
02:05PM  How Norfolk Southerns Carloads Stacked Up in Week 11
12:11PM  Did CSXs Intermodal Volumes Fall in Line in Week 11?
08:00AM  [$$] The Battle to Keep Veterans From Quitting Corporate Jobs at The Wall Street Journal
Mar-27-17 09:23AM  The Zacks Analyst Blog Highlights: Cisco, Philip Morris, McDonald's, General Dynamics, Union Pacific and Cintas
07:37AM  What Analysts Recommend for FedEx after 3Q17 Results
Mar-23-17 09:05AM  How Did GWRs North American Carloads Trend in February 2017?
07:36AM  Did Coal Push Up Canadian Pacifics Carloads in the 10th Week?
Mar-22-17 05:10PM  Winter Park Express ski train's success may mean changes next year (Video) at bizjournals.com
07:36AM  BNSF Railway Saw Growth in Carloads Volume
Mar-21-17 10:37AM  How Did Union Pacifics Intermodal Volumes Fare?
09:07AM  How Union Pacifics Carloads Compare to BNSF Railways
07:37AM  How Norfolk Southerns Carloads Stacked Up against Peers
Mar-20-17 03:15PM  Union Pacific Implores Photographers: Do Not Take Pictures On or Near Railroad Tracks #photosafety PR Newswire
Mar-17-17 09:00AM  Union Pacific Announces Annual Payments of Interest on Certain Bonds and Debentures PR Newswire
07:36AM  Analyzing Canadian Pacifics Carloads in the 9th Week
Mar-16-17 07:01AM  Coal isn't dead yet and the railroads are loving it
Mar-15-17 11:02AM  Union Pacific Could Track Sharply Lower
10:38AM  How Did Union Pacifics Intermodal Volumes Fare Last Week?
09:15AM  For an Inflation Hedge, Jump Aboard This Railroad Monopoly
09:06AM  Did Coal Boost Union Pacifics Carloads?
07:37AM  These Commodities Boosted Norfolk Southerns Carloads
Mar-14-17 03:35PM  Northeast storm hits transport stocks
10:01AM  Mosier derailment, fire recalled as Legislature takes up oil-train regulations at bizjournals.com
06:12AM  Coverage initiated on Union Pacific by Wells Fargo
Mar-13-17 06:00AM  An Ideal Investment for Long-Term Investors at Morningstar
Mar-10-17 07:07PM  Official: Fire still burning hours after Iowa derailment
11:36AM  The Latest: Company: Train with ethanol in fiery derailment
Mar-09-17 10:31AM  Federal court dismisses Union Pacific's lawsuit in Gorge track expansion dispute at bizjournals.com
Mar-08-17 11:04AM  UNION PACIFIC CORP Files SEC form 8-K, Regulation FD Disclosure
07:36AM  Unloading Canadian Pacifics Latest Carloads
Mar-07-17 11:02AM  [$$] Miss the CSX Rally? Try Norfolk Southern at Barrons.com
10:36AM  Your Guide to BNSF Railways Latest Carload Data
09:07AM  A Birds Eye View of CSXs Intermodal Volumes in the 8th Week
Mar-06-17 04:05PM  These Commodity Groups Boosted Union Pacifics Carloads Last Week
02:35PM  Where Norfolk Southerns Carloads Stand in the Industry Now
12:45PM  Unpacking Union Pacifics Intermodal Volumes
Mar-03-17 01:13PM  Caltrain's firing of safety project contractor not expected to further slow completion at bizjournals.com
07:37AM  Is Berkshires BNSF Finally on the Fast Track?
Mar-01-17 09:30AM  Union Pacific Corporation CFO Rob Knight to Address the Raymond James 38th Annual Institutional Investors Conference PR Newswire
Feb-28-17 10:37AM  Looking at CSXs Intermodal Volumes in the 7th Week of 2017
09:08AM  Comparing Canadian Pacifics Carloads
09:08AM  How Union Pacifics Intermodal Volumes Fared
07:38AM  Comparing Union Pacifics Carloads
Feb-27-17 05:35PM  Which Commodity Groups Boosted Norfolk Southerns Carloads?
03:05PM  Will Hunter Harrisons Entry Be a New Dawn at CSX?
Feb-23-17 03:28PM  Union Pacific Police Pursues Prestigious CALEA Accreditation PR Newswire
09:05AM  How Canadian Pacifics Stand up to Rival Canadian National
Feb-22-17 09:06AM  These Commodity Groups Pushed BNSF Railways Carloads
07:36AM  The Story behind Union Pacifics Intermodal Volumes
04:21AM  Union Pacific (UNP) Up 3.4% Since Earnings Report: Can It Continue?
Feb-21-17 04:58PM  Expeditors (EXPD) Beats on Q4 Earnings, Revenues
Union Pacific Corporation, through its subsidiary, Union Pacific Railroad Company, operates railroads in the United States. It offers transportation services for agricultural products, including grains, commodities produced from grains, and food and beverage products; automotive products, such as finished vehicles and automotive parts; and chemicals comprising industrial chemicals, plastics, fertilizers, petroleum and liquid petroleum gases, crude oil, and soda ash. The company also provides transportation services for coal, petroleum coke, and biomass; industrial products consisting of construction products, minerals, consumer goods, metals, lumber, paper, and other miscellaneous products; and intermodal import and export container traffic. Its rail network includes 32,070 route miles linking the Pacific Coast and Gulf Coast ports with the Midwest and Eastern United States gateways. Union Pacific Corporation was founded in 1862 and is headquartered in Omaha, Nebraska.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Whited Elizabeth FEVP & CHIEF MARKETING OFFICERMar 10Option Exercise31.191,00031,19050,583Mar 13 11:36 AM
Whited Elizabeth FEVP & CHIEF MARKETING OFFICERMar 10Sale106.891,000106,89049,583Mar 13 11:36 AM
Card Andrew H JRDirectorJan 25Option Exercise24.257,400179,45022,400Jan 26 10:44 AM
Card Andrew H JRDirectorJan 25Sale109.534,000438,12918,400Jan 26 10:44 AM
MCCONNELL MICHAEL WDirectorDec 09Option Exercise24.257,400179,45026,410Dec 12 10:56 AM
BUTLER ERIC LEVP & CHIEF ADMIN OFFICERDec 09Option Exercise39.1327,0681,059,287234,784Dec 12 03:30 PM
BUTLER ERIC LEVP & CHIEF ADMIN OFFICERDec 09Sale104.9423,1982,434,398222,062Dec 12 03:30 PM
MCCONNELL MICHAEL WDirectorDec 09Sale105.157,400778,11919,010Dec 12 10:56 AM
ROGEL STEVEN RDirectorNov 22Option Exercise24.257,400179,45011,400Nov 23 10:51 AM
ROGEL STEVEN RDirectorNov 22Sale100.517,400743,7474,000Nov 23 10:51 AM
DUREN DIANE KEVP CHIEF ADMIN OFFICER & CORPNov 18Sale98.982,840281,103128,701Nov 21 02:14 PM
Scott Cameron AEVP & CHIEF OPERATING OFFICEROct 07Option Exercise66.006,484427,94471,320Oct 11 08:58 AM
Scott Cameron AEVP & CHIEF OPERATING OFFICEROct 07Sale98.446,484638,28564,836Oct 11 08:58 AM
KNIGHT ROBERT M JREVP & CHIEF FINANCIAL OFFICERSep 07Sale97.005,000485,00032,723Sep 09 11:09 AM
KNIGHT ROBERT M JREVP & CHIEF FINANCIAL OFFICERSep 01Sale95.2410,000952,41537,723Sep 02 03:51 PM
DUREN DIANE KEVP & CORPORATE SECRETARYJun 03Sale85.462,500213,650131,541Jun 06 12:25 PM
BIIB Biogen Inc. daily Stock Chart
BIIB [NASD]
Biogen Inc.
IndexS&P 500 P/E16.14 EPS (ttm)16.91 Insider Own0.10% Shs Outstand215.54M Perf Week0.39%
Market Cap58.83B Forward P/E12.22 EPS next Y22.34 Insider Trans-7.31% Shs Float215.31M Perf Month-1.77%
Income3.70B PEG2.44 EPS next Q4.98 Inst Own89.90% Short Float1.20% Perf Quarter-2.75%
Sales11.45B P/S5.14 EPS this Y10.30% Inst Trans0.60% Short Ratio1.58 Perf Half Y-7.52%
Book/sh56.05 P/B4.87 EPS next Y6.61% ROA17.00% Target Price313.90 Perf Year-2.38%
Cash/sh22.71 P/C12.02 EPS next 5Y6.62% ROE32.20% 52W Range223.02 - 333.65 Perf YTD-3.75%
Dividend- P/FCF15.50 EPS past 5Y27.40% ROI21.00% 52W High-18.20% Beta0.81
Dividend %- Quick Ratio2.30 Sales past 5Y17.80% Gross Margin87.10% 52W Low22.38% ATR4.42
Employees7400 Current Ratio2.60 Sales Q/Q1.20% Oper. Margin45.00% RSI (14)46.83 Volatility1.34% 1.45%
OptionableYes Debt/Eq0.54 EPS Q/Q-20.60% Profit Margin32.30% Rel Volume0.69 Prev Close272.46
ShortableYes LT Debt/Eq0.54 EarningsApr 25 BMO Payout0.00% Avg Volume1.64M Price272.94
Recom2.20 SMA200.42% SMA50-2.68% SMA200-6.20% Volume1,124,940 Change0.18%
Mar-16-17Downgrade Morgan Stanley Overweight → Equal-Weight
Mar-16-17Downgrade Leerink Partners Outperform → Mkt Perform
Mar-02-17Initiated Instinet Buy $345
Feb-07-17Upgrade Citigroup Neutral → Buy
Dec-29-16Reiterated Raymond James Strong Buy $375 → $386
Dec-09-16Reiterated Stifel Hold $291 → $298
Nov-08-16Initiated Mizuho Buy $290
Nov-07-16Upgrade Piper Jaffray Neutral → Overweight
Nov-07-16Upgrade Leerink Partners Mkt Perform → Outperform
Sep-06-16Downgrade Jefferies Buy → Hold
Jun-29-16Initiated Bernstein Outperform
Jun-07-16Downgrade Citigroup Buy → Neutral
Feb-25-16Initiated Citigroup Buy $345
Jan-20-16Initiated Credit Suisse Neutral
Jan-07-16Initiated Standpoint Research Buy $360
Dec-04-15Resumed Wells Fargo Outperform
Oct-22-15Reiterated H.C. Wainwright Buy $380 → $360
Sep-09-15Initiated Jefferies Buy
Sep-01-15Initiated Raymond James Strong Buy $400
Aug-11-15Initiated H.C. Wainwright Buy $380
Apr-23-17 11:01AM  3 Stocks That Growth Investors Should Love Motley Fool
Apr-21-17 04:13PM  Street Watches To See If $125,000 Drug Boosts Biogen's Results Investor's Business Daily
02:38PM  Biogen Says It's Back and Ready for Highly Active Dealmaking Bloomberg
02:00PM  Biogens SPINRAZA® (nusinersen) Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy Business Wire
Apr-20-17 05:53PM  What to expect from biotech CNBC Videos
10:16AM  What's in Store for Biogen (BIIB) this Earnings Season? Zacks
09:42AM  Innoviva director vote drama hands last-minute loss to Sarissa Reuters
Apr-19-17 10:09PM  Activist Sarissa says Innoviva backed out of proxy settlement deal Reuters
11:42AM  Gilead Sciences: Who's Frustrated Now? Barrons.com
07:57AM  Biotech Stock Roundup: FDA CRL Hits Incyte, Pipeline Setbacks Weigh on OncoMed Zacks
Apr-18-17 10:55AM  Biogen to unveil new data supporting broad use of infant disease drug American City Business Journals
07:30AM  Biogen Highlights Advances from Its Neurology Research Programs and Portfolio of Innovative Medicines at AAN Congress Business Wire
Apr-17-17 09:37AM  Biogen to License Alzheimer Candidate from Bristol-Myers Zacks
Apr-14-17 09:51AM  How Biogen's Takeover Prospects Soured In Mere Months Investor's Business Daily
09:38AM  Biogen Snaps Up A 'Rare Find' From BMS: Instinet Barrons.com
Apr-13-17 04:40PM  Could Bristol's Drug Help Biogen Take AbbVie In Alzheimer's? Investor's Business Daily
10:20AM  Biogen pays $300M to Bristol-Myers for another potential Alzheimer's drug American City Business Journals
09:21AM  Biotech Movers: Synergy, Biogen, Insys TheStreet.com
08:29AM  Bristol-Myers to license two drugs to Biogen, Roche Reuters
07:23AM  Bristol-Myers to license two of its drugs to Biogen, Roche Reuters
07:11AM  Bristol-Myers to get $470 million upfront for license deals with Biogen and Roche MarketWatch
07:00AM  Biogen Licenses Phase 2 Anti-Tau Antibody from Bristol-Myers Squibb Business Wire
Apr-12-17 12:51PM  How These Biotechs Could Save The Drug Sector In Q1 Or Not Investor's Business Daily
11:25AM  [$$] Celgene, Biogen to Gain From Higher Prices Barrons.com
10:13AM  Don't Get Your Hopes Up For Biotech's Q1 Earnings Barrons.com
08:15AM  Post Earnings Coverage as NeuroDerm Reported FY16 Results Accesswire
06:00AM  First Quarter Earnings Preview: Biotech Heavyweights Investopedia
Apr-10-17 01:04PM  Roche Just Scored One of the Biggest Pharma Wins of 2017 Motley Fool
Apr-07-17 04:45PM  How Roche's 'Game Changer' Drug Will Chip Away At Biogen, Novartis Investor's Business Daily
01:34PM  Why Roche's New Drug Is Bad News For Biogen Barrons.com
11:40AM  Biogen multiple sclerosis drug sales could fall $900M by 2020, analyst predicts American City Business Journals
Apr-04-17 05:40PM  Why AbbVie Will be an Incredible Money-Making Machine in an Overvalued Stock Market TheStreet.com
05:40PM  Why AbbVie Will be an Incredible Money-Making Machine in an Overvalued Stock Market
Apr-03-17 04:43PM  Acorda, Forward, Biogen Fall On Multiple Sclerosis Drug Fight Investor's Business Daily
04:43PM  Acorda, Forward, Biogen Fall On Multiple Sclerosis Drug Fight
04:19PM  Snap Started At Hold, Kite Pharma Can't Stay Aloft, Accenture Cut Investor's Business Daily
04:19PM  Snap Started At Hold, Kite Pharma Can't Stay Aloft, Accenture Cut
Apr-02-17 07:23AM  5 Deadliest Diseases in the U.S. -- and the Top Drugs Potentially on the Way to Treat Them Motley Fool
07:23AM  5 Deadliest Diseases in the U.S. -- and the Top Drugs Potentially on the Way to Treat Them at Motley Fool
Mar-31-17 05:14PM  Why Acorda Therapeutics Inc and Forward Pharma A/S Got Crushed Today Motley Fool
05:14PM  Why Acorda Therapeutics Inc and Forward Pharma A/S Got Crushed Today at Motley Fool
04:25PM  Acorda, Forward Stocks Plunge On Multiple Sclerosis Court Rulings Investor's Business Daily
04:25PM  Acorda, Forward Stocks Plunge On Multiple Sclerosis Court Rulings
03:57PM  Two biotech stocks plunge after losing patent fights CNBC
03:57PM  Two biotech stocks plunge after losing patent fights at CNBC
02:45PM  Biogen wins another big Tecfidera patent case at bizjournals.com
02:45PM  Biogen wins another big Tecfidera patent case American City Business Journals
01:02PM  Biogen wins Tecfidera U.S. patent dispute with Forward Pharma Reuters
01:02PM  Biogen wins Tecfidera U.S. patent dispute with Forward Pharma
12:41PM  Acorda Therapy tanks
12:27PM  Biogen stock rises, Forward Pharma halted down 20% after patent ruling at MarketWatch
12:15PM  Forward Pharma Falls On Biogen Patent Victory Over MS Drug Ingredient
12:10PM  Forward Pharma plunges on patent ruling
10:36AM  Novartis Expects to Launch 5 Key Biosimilars by 2020
09:43AM  Can Vertex Keep Climbing? at Barrons.com
Mar-29-17 05:43PM  Roche's Ocrevus Wins FDA Approval for 2 Forms of Sclerosis at Investopedia
04:31PM  Roche Multiple Sclerosis Drug OK Bittersweet For Beleaguered Biogen
09:26AM  U.S. approves Roche drug that targets severe form of MS Reuters
05:40AM  UPDATE 2-Roche MS drug Ocrevus approved by FDA after 3-month delay Reuters
Mar-28-17 08:45PM  Roche Wins FDA Backing for New Multiple Sclerosis Therapy, Competition Could Crimp Biogen
09:07AM  Could International Laggards Come Out as Winners?
07:30AM  Biogen to Present Data at the 13th International Conference on Alzheimers and Parkinsons Diseases Business Wire
Mar-27-17 04:01PM  Biogen to Report First Quarter 2017 Financial Results on April 25, 2017 Business Wire
10:30AM  Short Interest Pulls Back in Major Biotechs
Mar-22-17 03:10PM  Cytokinetics SMA Drug Did Well in Early Study at Investopedia
12:53PM  Could Biogen Spinoff Bleed This Biotech In Hemophilia?
10:37AM  Recent Developments for Ionis Pharmaceuticals
08:33AM  Biotech Stock Roundup: Amgen Down on Repatha Data, Nektar Surges on Pain Results
07:37AM  A Look at Ionis Pharmaceuticals Spinraza
12:07AM  [$$] Two Cheers for Biogens Court Victory at The Wall Street Journal
Mar-21-17 04:43PM  Biogen Wins Tecfidera Patent Case at Investopedia
04:04PM  Biogen Stock Pops After Judge Upholds Critical Drug Patent
02:13PM  Biogen wins patent decision
01:44PM  Biogen: Did Someone Say Biotech Stocks are Falling? at Barrons.com
12:52PM  [$$] Two Cheers for Biogen's Court Victory at The Wall Street Journal
12:26PM  Biogen wins ruling in Tecfidera IP case; shares rise
12:05PM  Understanding Ionis Pharmaceuticals 2016 Revenue Stream
11:45AM  Biogen prevails in dispute over key Tecfidera patent at bizjournals.com
09:25AM  3 Biotech Stocks That Are Broker Favorites
09:07AM  Better Buy: Ionis Pharmaceuticals, Inc. vs. Juno Therapeutics at Motley Fool
08:17AM  Biogen, Inc. breached its 50 day moving average in a Bearish Manner : BIIB-US : March 21, 2017
Mar-20-17 04:24AM  European Stocks Drift Lower; Deutsche Bank Falls on Rights Issue Details
03:00AM  European Stocks Set For Mixed Open: Dollar Slumps in Quiet Asia Trade
Mar-17-17 05:44PM  Week in Review: Stocks Post Small Gains After Fed Pulls Trigger on Third Hike Since Crisis
11:44AM  AveXis Inc Stock Is Spiking Again Today -- Here's Why at Motley Fool
10:29AM  Get Ready For A Slew of Data As Weekend Nears
10:25AM  AveXis Reports Positive Data for SMA Gene Therapy at Investopedia
07:39AM  Why Did the Healthcare Sector Fall on March 16?
Mar-16-17 04:24PM  US STOCKS-Wall St slips with healthcare stocks, Nasdaq flat
04:24PM  The Biggest Loser: Biogen Tumbles 4.7% at Barrons.com
04:05PM  Biogen Dives As Takeover Buzz Fades, Drugs Hit Snags
03:12PM  Stock market pares post-Fed bounce as health care, utilities slump at MarketWatch
02:32PM  Biogen, LendingClub, IBM, and More: Heres What Analysts Had to Say About These Five Stocks at Insider Monkey
12:58PM  US STOCKS-Wall St edges down as healthcare stocks hit by budget plan
12:13PM  Cramer: Confusion Reigns in This Market
12:08PM  Biogen stock drops 5.5% after downgrades at Morgan Stanley, Leerink at MarketWatch
11:32AM  US STOCKS-Wall St slightly lower as healthcare stocks weigh
11:25AM  Biogen: Double Trouble? at Barrons.com
10:41AM  Biogen's Catalysts May Be Waning; Leerink Downgrades To Market Perform
10:06AM  Biogen shares drop after Morgan Stanley downgrade; rest of biotech also dragged lower at CNBC
Biogen Inc., a biopharmaceutical company, discovers, develops, manufactures, and delivers therapies for the treatment of neurological and autoimmune diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA to treat multiple sclerosis (MS); FUMADERM for the treatment of plaque psoriasis; and SPINRAZA to treat spinal muscular atrophy. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), and other conditions; GAZYVA to treat CLL and follicular lymphoma; and other potential anti-CD20 therapies. The company's Phase III clinical trial products comprise GAZYVA for the treatment of front-line indolent non-hodgkin's lymphoma; and Aducanumab and E2609 for Alzheimer's disease. Its Phase II clinical trial products include BIIB074 for trigeminal neuralgia, lumbosacral radiculopathy, and erythromelalgia; BAN2401 for Alzheimer's disease; Opicinumab (anti-LINGO-1) for MS; TYSABRI for acute ischemic stroke; rAAV-XLRS for X-linked juvenile retinoschisis; BG00011 (STX-100) for idiopathic pulmonary fibrosis; and Dapirolizumab pegol and BIIB059 (Anti-BDCA02) for lupus. The company's Phase I clinical trial products comprise BIIB061 for MS; BIIB054 for Parkinson's disease; BIIB067 (IONIS-SOD1Rx) for amyotrophic lateral sclerosis; and BIIB068 (BTK Inhibitor) for autoimmune disease. It has collaboration agreements with AbbVie, Inc.; Acorda Therapeutics, Inc.; Applied Genetic Technologies Corporation; Eisai Co., Ltd.; Genentech, Inc.; Ionis Pharmaceuticals, Inc.; Samsung Bioepis; and University of Pennsylvania. Biogen Inc. offers products through its sales force and marketing groups. The company was formerly known as Biogen Idec Inc. and changed its name to Biogen Inc. in March 2015. Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sandrock AlfredEVP CMO Neuro & NeurodegeneratApr 03Sale274.081,981542,9527,060Apr 04 04:18 PM
Clancy Paul JExecutive VP and CFOMar 13Sale291.559,8912,883,72120,705Mar 14 07:32 PM
McKenzie PaulEVP Pharmaceutical Oper & TechMar 01Option Exercise0.004810718Mar 03 06:07 PM
Sandrock AlfredEVP CMO Neuro & NeurodegeneratMar 01Sale290.07973282,2389,041Mar 03 06:02 PM
Clancy Paul JExecutive VP and CFOFeb 28Option Exercise0.006,780031,948Mar 02 05:24 PM
Sandrock AlfredEVP CMO Neuro & NeurodegeneratFeb 28Option Exercise0.004,785010,398Mar 02 05:22 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 28Option Exercise0.005,559036,024Mar 02 05:20 PM
COVINO GREGORY FVP, Chief Accounting OfficerFeb 28Option Exercise0.0068104,508Mar 02 05:18 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffFeb 28Option Exercise0.002,06409,237Mar 02 05:16 PM
DiPietro KennethEVP Human ResourcesFeb 28Option Exercise0.005,69608,260Mar 02 05:12 PM
Vounatsos MichelChief Executive OfficerFeb 27Buy285.391,333380,4251,434Mar 01 04:18 PM
PANGIA ROBERT WDirectorJan 09Option Exercise52.225,450284,59922,078Jan 10 04:15 PM
PANGIA ROBERT WDirectorJan 09Sale295.395,4501,609,87616,628Jan 10 04:15 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffDec 01Sale296.534814,2337,360Dec 05 04:34 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffOct 04Sale311.9426281,7287,579Oct 05 04:24 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffOct 03Sale313.00380118,9407,841Oct 04 05:02 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffOct 01Option Exercise0.001,98209,154Oct 04 05:02 PM
DORSA CAROLINEDirectorSep 22Option Exercise53.6427,5701,478,85544,663Sep 26 04:24 PM
DORSA CAROLINEDirectorSep 22Sale314.0027,5708,656,98017,093Sep 26 04:24 PM
SCANGOS GEORGE AChief Executive OfficerJul 21Sale280.0015743,96054,779Jul 22 05:03 PM
Koppel AdamEVP, Strategy and Bus. Dev.Jun 06Sale290.00555160,9502,402Jun 07 04:09 PM
SCANGOS GEORGE AChief Executive OfficerJun 03Sale290.00842244,18054,936Jun 06 08:14 PM
Koppel AdamEVP, Strategy and Bus. Dev.Jun 02Option Exercise0.001,64303,491Jun 06 08:48 PM
SCANGOS GEORGE AChief Executive OfficerJun 01Sale287.97487140,24155,778Jun 02 04:39 PM
SCANGOS GEORGE AChief Executive OfficerMay 31Sale290.003,368976,72056,265Jun 02 04:39 PM
SCANGOS GEORGE AChief Executive OfficerMay 25Sale280.0015743,96059,633May 27 08:59 AM
SCANGOS GEORGE AChief Executive OfficerMay 02Sale274.74487133,79859,790May 04 05:03 PM
UNH UnitedHealth Group Incorporated daily Stock Chart
UNH [NYSE]
UnitedHealth Group Incorporated
IndexDJIA S&P500 P/E20.48 EPS (ttm)8.36 Insider Own0.50% Shs Outstand975.00M Perf Week3.76%
Market Cap166.88B Forward P/E15.86 EPS next Y10.79 Insider Trans-3.76% Shs Float961.75M Perf Month2.47%
Income8.11B PEG1.38 EPS next Q2.37 Inst Own86.90% Short Float1.00% Perf Quarter8.28%
Sales189.04B P/S0.88 EPS this Y20.60% Inst Trans-0.04% Short Ratio2.65 Perf Half Y19.47%
Book/sh45.12 P/B3.79 EPS next Y10.79% ROA6.00% Target Price186.81 Perf Year30.92%
Cash/sh19.85 P/C8.62 EPS next 5Y14.87% ROE19.40% 52W Range126.38 - 172.19 Perf YTD7.35%
Dividend2.50 P/FCF17.09 EPS past 5Y8.90% ROI11.40% 52W High-0.60% Beta0.61
Dividend %1.46% Quick Ratio- Sales past 5Y12.70% Gross Margin- 52W Low35.43% ATR2.20
Employees230000 Current Ratio- Sales Q/Q9.40% Oper. Margin7.10% RSI (14)69.31 Volatility1.60% 1.24%
OptionableYes Debt/Eq0.77 EPS Q/Q33.70% Profit Margin4.00% Rel Volume0.82 Prev Close171.54
ShortableYes LT Debt/Eq0.59 EarningsApr 18 BMO Payout31.60% Avg Volume3.65M Price171.16
Recom1.60 SMA203.16% SMA503.39% SMA20013.23% Volume2,981,797 Change-0.22%
Apr-18-17Reiterated Mizuho Buy $178 → $200
Apr-05-17Initiated Deutsche Bank Buy $183
Jan-04-17Initiated Piper Jaffray Overweight
Dec-07-16Upgrade Cantor Fitzgerald Hold → Buy
Nov-30-16Upgrade Mizuho Neutral → Buy $178
Nov-30-16Reiterated RBC Capital Mkts Outperform $168 → $175
Nov-09-16Downgrade Mizuho Buy → Neutral
Oct-19-16Reiterated Mizuho Buy $160 → $169
Jul-22-16Upgrade Argus Hold → Buy
Jul-20-16Reiterated RBC Capital Mkts Outperform $157 → $165
Jul-19-16Reiterated Mizuho Buy $156 → $160
Jun-16-16Initiated Bernstein Outperform
Jun-13-16Reiterated Mizuho Buy $156 → $156
Apr-20-16Reiterated Mizuho Buy $150 → $156
Apr-19-16Reiterated FBR Capital Outperform $130 → $145
Mar-15-16Reiterated Mizuho Buy $131 → $150
Dec-16-15Initiated Credit Suisse Outperform
Nov-20-15Reiterated Mizuho Buy $155 → $131
Nov-19-15Reiterated FBR Capital Outperform $135 → $130
Oct-02-15Initiated Citigroup Buy
Apr-21-17 05:56PM  Dow 30 Stock Roundup: AmEx, UNH Beat; Goldman, JNJ, Verizon Disappoint Zacks
04:25PM  Week In Review: Dow Rebounds On Trump; IBM, Netflix, Goldman Disappoint Investor's Business Daily
10:57AM  Edited Transcript of UNH earnings conference call or presentation 18-Apr-17 12:45pm GMT Thomson Reuters StreetEvents
12:20AM  Insurers Offer Early Sign of ACA Exchange Plans for 2018 The Wall Street Journal
Apr-20-17 06:21PM  UnitedHealthcare Invests $12 Million in PATHs New Supportive-Housing Community in Los Angeles to Serve Homeless and Low-Income Individuals and Families Business Wire
05:34PM  New Affordable-Housing Community in the Bronx Provides Opportunity for People with Mental Disabilities to Live Independently Business Wire
05:33PM  US Market Indexes Gain With Positive Corporate Earnings GuruFocus.com
08:15AM  Post Earnings Coverage as UnitedHealth Group Quarterly Revenue Grew 9.4%; Adjusted EPS Soared 31% Accesswire
05:30AM  Insurers Offer Early Sign of ACA Exchange Plans for 2018 The Wall Street Journal
Apr-19-17 11:55AM  UnitedHealth shuffles executives, names new UnitedHealthcare CEO American City Business Journals
08:07AM  As Hospitals Fade, UnitedHealth's OptumCare Moves Into Their Communities Forbes
01:09AM  [$$] UnitedHealth Profits Rise as it Exits Health-Care Exchanges The Wall Street Journal
Apr-18-17 07:01PM  Cramer: Without an Economic Win, We Are Hostage to Oil TheStreet.com
04:02PM  UPDATED: Goldman's stock decline cuts more than 70 points from the Dow MarketWatch
04:02PM  Dow's UnitedHealth Rises On Blowout Q1 Earnings Investor's Business Daily
03:56PM  Addiction Experts Target Treatment Centers MarketWatch
03:34PM  UnitedHealth Warns Insurer Tax Could Take a Bite Out of 2018 TheStreet.com
03:02PM  UnitedHealth's Government Growth Can't Be Ignored Bloomberg
01:48PM  UnitedHealth raises its 2017 outlook despite the uncertainty over Obamacare repeal CNBC
12:59PM  The CEO of America's largest health insurer said he doesn't know any more about the GOP's Obamacare plans than you Business Insider
12:09PM  UnitedHealth plans for costly Obamacare tax in 2018 Reuters
11:30AM  Strong First Quarter Leads UnitedHealth to Boost 2017 Outlook TheStreet.com
11:24AM  [$$] UnitedHealth Profits Rise as it Exits Exchanges The Wall Street Journal
10:48AM  Stock Market News for April 18, 2017 Zacks
10:40AM  UnitedHealth 1Q profit soars as ACA business shrinks Associated Press
09:59AM  UnitedHealth Surges on Obamacare Withdrawal Motley Fool
09:52AM  UnitedHealth (UNH) Q1 Earnings Beat on Membership Growth Zacks
09:30AM  UnitedHealth's Optum Profits Overcome Obamacare Exit Forbes
09:04AM  UnitedHealth planning for costly 2018 health insurance tax Reuters
08:26AM  UnitedHealth Stock Rises on First-Quarter Earnings Beat, Raised Guidance TheStreet.com
07:59AM  Early movers: UNH, JNJ, BAC, HOG, NFLX, TSLA, CAB, BUFF & more CNBC
07:50AM  How Dumping ACA Exchanges Boosted UnitedHealths Profits 24/7 Wall St.
07:08AM  UnitedHealth tops Street 1Q forecasts Associated Press
06:51AM  UnitedHealth crushes earnings in its first quarter since dumping most of its Obamacare business Business Insider
06:26AM  UnitedHealth's (UNH) Q1 Earnings Beat on Higher Revenues Zacks
06:25AM  Insurer UnitedHealth's quarterly profit, revenue beats Reuters
06:04AM  Health insurer UnitedHealth revenue rises 9.4 pct Reuters
06:03AM  U.S. stocks set for losses, with Bank of America earnings ahead MarketWatch
05:55AM  UnitedHealth Group First Quarter Highlights Business Wire
Apr-17-17 07:00PM  Trumponomics  Founders In Chesapeake Bay Forbes
05:37PM  US Market Indexes Higher on Monday GuruFocus.com
05:13PM  UnitedHealth Seen as Ready to Weather Obamacare Rewrite TheStreet.com
04:59PM  Stocks, Dow Industrials Up, Oil Off; Zayo Breaks Out; Will Snap Hit New Low? Investor's Business Daily
04:36PM  Facebook's F8 Begins; 4 Dow Stocks Report Earnings: Investing Action Plan Investor's Business Daily
04:29PM  Stocks, Dow Industrials Up, Oil Off; Zayo Breaks Out; Will Snap Hit New Low? Investor's Business Daily
03:23PM  UnitedHealth to Test Durability of 2017's Strong Start TheStreet.com
10:28AM  [$$] UnitedHealth Earnings: What to Watch The Wall Street Journal
09:07AM  Should You Buy UnitedHealth Group (UNH) Ahead of Earnings? Zacks
09:02AM  UnitedHealth (UNH) Poised to Beat on Q1 Earnings: Here's Why Zacks
08:38AM  How To Trade Goldman Sachs, IBM And Two Others That Report Earnings This Week Forbes
Apr-16-17 07:53AM  2 Things Obamacare Got Very, Very Wrong Motley Fool
Apr-15-17 09:50AM  Top Dow Earnings to Watch For This Coming Week 24/7 Wall St.
Apr-14-17 06:41PM  Earnings Preview: What To Expect From UnitedHealth On Tuesday Forbes
08:24AM  UnitedHealth Group, Inc. breached its 50 day moving average in a Bearish Manner : UNH-US : April 14, 2017 Capital Cube
07:47AM  Trump's Obamacare Subsidy Threat Is Bad Timing For Insurers Forbes
Apr-13-17 07:28PM  Greater Hartford Arts Council Awards $10,000 in Grants to Support Arts Programs for Citizens With Disabilities Business Wire
06:23PM  Trump administration issues final rule on stricter Obamacare enrollment Reuters
04:58PM  Aetna (AET) Hurt by Exchange Business, High Medical Costs Zacks
04:20PM  UnitedHealthcare and Optum Support People Affected by Wildfires in Florida Business Wire
04:13PM  UnitedHealthcare Donates Hasbro's NERF ENERGY Game Kits to Boys & Girls Clubs of Metropolitan Baltimore to Encourage Physical Activity Business Wire
Apr-12-17 05:54PM  Trump may halt insurer payments to force Democrats to table on healthcare Reuters
09:43AM  Should You Retain Universal Health (UHS) Stock in Portfolio? Zacks
Apr-11-17 06:17PM  Orlando Magic Players Nikola Vucevic and Damjan Rudez, Head Coach Frank Vogel, Magic Staff and UnitedHealthcare Fight Hunger in Central Florida Marketwired
Apr-10-17 09:47AM  Buy 7 Stocks with Impressive Interest Coverage Ratio Zacks
09:30AM  Here's Why You Should Dump Tenet Healthcare (THC) Stock Now Zacks
Apr-08-17 07:45AM  Obamacare: We Hate It, Love It, and Really Don't Have a Clue What It Does Motley Fool
Apr-07-17 04:01PM  Wal-Mart, Verizon Give DJIA a Slight Push on Friday 24/7 Wall St.
08:04AM  3 Top Medicare Companies to Buy in 2017 Motley Fool
Apr-06-17 09:16PM  Baton Rouge Area Foundation Receives $250,000 Grant from UnitedHealthcare to Help with Relief and Recovery Efforts from the Floods in Southeast Louisiana Business Wire
12:01PM  Health Carriers Hanging Tough Despite D.C. Debacle Investopedia
09:55AM  UnitedHealthcare of Texas names new Houston-based CEO American City Business Journals
Apr-05-17 02:09PM  The Mutual Fund That Is a Top 10 Guru GuruFocus.com
11:06AM  Should You Retain Acadia Healthcare Stock in Your Portfolio? Zacks
Apr-04-17 05:42PM  3 Top Medicaid Stocks to Buy in 2017 Motley Fool
04:39PM  3 Reason to Stay Away From Anthem's Stock TheStreet.com
11:04AM  UnitedHealth Group, Inc. : UNH-US: Dividend Analysis : March 10th, 2017 (record date) : By the numbers : April 4, 2017 Capital Cube
10:13AM  WellCare and Catholic Health Team Up to Improve Health Care Zacks
07:45AM  Mylan Copes With New Lawsuit and EpiPen Recall (MYL) Investopedia
Apr-03-17 06:03PM  U.S. raises Medicare payments to insurers by 0.45 pct in 2018 Reuters
05:01PM  U.S. to raise Medicare payments to insurers 0.45 percent in 2018 Reuters
04:26PM  Volatile Session Ends As Nasdaq Retreats From Record High, Tesla Breaks Out
03:58PM  Mylan hit with new class action lawsuit over EpiPen pricing Reuters
01:36PM  4 Stocks Expected to Hike Dividends 20% or More this Quarter at Barrons.com
11:30AM  US stocks turn lower on Wall Street as automakers sink
09:42AM  Stocks Open Higher; United Therapeutics Dives
Apr-02-17 08:29AM  Yes, Obamacare Is Here to Stay -- and Yes, It's Probably Going to Fail at Motley Fool
Apr-01-17 04:23PM  ACA Repeal and Replace: Lots of Plans but No Plan B
Mar-31-17 11:07AM  Drug Middlemen Have Slim Profit Margins -- Just Ask Them
09:32AM  Community Health Completes Tender Offer for Senior Notes
Mar-30-17 07:30PM  US Market Indexes Higher on Thursday With Gains From Financials
04:26PM  Stock market closes higher on bank-led gains after positive economic data at MarketWatch
02:39PM  UnitedHealthcare, Premier Health Contract Impasse Threatens 80K Plans
08:27AM  UnitedHealth Group, Inc. breached its 50 day moving average in a Bearish Manner : UNH-US : March 30, 2017
Mar-29-17 06:49PM  US Market Indexes Gain on Wednesday
05:58PM  GDP check What you need to know in markets on Thursday
04:44PM  3 Top Health Insurance Stocks to Buy in 2017 at Motley Fool
04:28PM  Nasdaq closes for 4th straight gain, as Dow lags behind at MarketWatch
04:01PM  UnitedHealth, Travelers Sink DJIA Wednesday
11:31AM  US STOCKS-S&P, Nasdaq lifted by energy, discretionary stocks
08:07AM  SHYFT Announces Strategic Investment From Optum PR Newswire
UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. The company's UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, individuals, and military service members; and health care coverage, and health and well-being services to individuals aged 50 and older addressing their needs for preventive and acute health care services. It also provides services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; and health services, including commercial health and dental benefits. This segment serves through a network of 1 million physicians and other health care professionals, as well as approximately 6,000 hospitals and other facilities. Its OptumHealth segment offers health management services, including care delivery and management, wellness and consumer engagement, distribution, and health financial services. This segment serves individuals through programs offered by employers, payers, government entities, and directly with the care delivery systems. The company's OptumInsight segment provides software and information products, and business process outsourcing and support services to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. Its OptumRx segment offers pharmacy care services and programs, including retail network contracting, home delivery and specialty pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BALLARD WILLIAM C JRDirectorApr 20Option Exercise52.225,000261,10075,735Apr 21 04:37 PM
BALLARD WILLIAM C JRDirectorApr 20Sale170.475,000852,32570,735Apr 21 04:37 PM
WILSON D ELLENEVP Human CapitalApr 19Sale170.5414,0002,387,61031,993Apr 21 04:39 PM
Shine Kenneth IrwinDirectorApr 19Sale169.12838141,71828,528Apr 21 04:38 PM
BURKE RICHARD TDirectorMar 27Option Exercise53.735,000268,6501,876,270Mar 29 05:50 PM
HOOPER MICHELE JDirectorMar 16Option Exercise39.5215,000592,75035,941Mar 20 04:50 PM
HOOPER MICHELE JDirectorMar 16Sale170.8915,0002,563,34530,941Mar 20 04:50 PM
DARRETTA ROBERT JDirectorMar 15Option Exercise54.0216,621897,94955,134Mar 16 05:02 PM
BURKE RICHARD TDirectorMar 02Sale167.4850,0008,373,9251,871,191Mar 06 04:52 PM
WILENSKY GAIL RDirectorFeb 23Option Exercise53.785,310285,56760,175Feb 24 04:42 PM
WILENSKY GAIL RDirectorFeb 23Sale162.315,310861,88555,175Feb 24 04:42 PM
BALLARD WILLIAM C JRDirectorFeb 14Option Exercise53.735,000268,65075,391Feb 15 04:50 PM
BALLARD WILLIAM C JRDirectorFeb 14Sale162.685,000813,40070,391Feb 15 04:50 PM
BURKE RICHARD TDirectorJan 31Sale161.6810,0001,616,7501,921,191Feb 02 05:28 PM
BURKE RICHARD TDirectorJan 23Option Exercise52.2189046,4671,931,191Jan 25 04:17 PM
BURKE RICHARD TDirectorDec 29Option Exercise52.575,000262,8501,930,030Jan 03 04:34 PM
Bueno Edson de GodoyDirectorDec 21Option Exercise55.0357,2003,147,716207,817Dec 22 08:55 PM
BURKE RICHARD TDirectorDec 15Sale159.8015,0002,397,0001,925,030Dec 15 04:36 PM
BURKE RICHARD TDirectorDec 08Sale158.6645,0007,139,4891,944,949Dec 09 04:09 PM
ROOS THOMAS EChief Accounting OfficerDec 06Sale157.602,000315,20321,083Dec 08 04:24 PM
WILENSKY GAIL RDirectorNov 17Option Exercise52.545,460286,86760,512Nov 21 04:10 PM
WILENSKY GAIL RDirectorNov 17Sale150.555,460822,00055,052Nov 21 04:10 PM
BALLARD WILLIAM C JRDirectorNov 14Sale151.213,000453,61570,039Nov 16 04:22 PM
WILSON D ELLENEVP Human CapitalOct 21Option Exercise46.1816,275751,58066,635Oct 25 05:07 PM
Shine Kenneth IrwinDirectorOct 21Sale144.9932547,12128,613Oct 25 05:08 PM
WILSON D ELLENEVP Human CapitalOct 21Sale144.1814,3652,071,10552,270Oct 25 05:07 PM
BURKE RICHARD TDirectorSep 14Option Exercise49.325,990295,4421,989,540Sep 15 05:13 PM
BURKE RICHARD TDirectorSep 07Sale135.3140,0005,412,2161,983,550Sep 09 04:52 PM
BALLARD WILLIAM C JRDirectorAug 25Option Exercise52.575,000262,85072,630Aug 29 04:32 PM
BALLARD WILLIAM C JRDirectorJun 16Option Exercise49.435,000247,15072,229Jun 20 04:27 PM
BURKE RICHARD TDirectorJun 16Option Exercise45.415,840265,2192,023,149Jun 20 04:28 PM
BALLARD WILLIAM C JRDirectorJun 16Sale138.585,000692,89567,229Jun 20 04:27 PM
BURKE RICHARD TDirectorMay 13Sale129.3025,0003,232,5332,017,309May 17 04:34 PM
EPD Enterprise Products Partners L.P. daily Stock Chart
EPD [NYSE]
Enterprise Products Partners L.P.
Index- P/E26.11 EPS (ttm)1.06 Insider Own0.30% Shs Outstand2.12B Perf Week0.14%
Market Cap58.73B Forward P/E17.69 EPS next Y1.57 Insider Trans0.35% Shs Float1.43B Perf Month1.99%
Income2.50B PEG3.66 EPS next Q0.33 Inst Own37.00% Short Float1.36% Perf Quarter-0.61%
Sales23.02B P/S2.55 EPS this Y-20.90% Inst Trans0.02% Short Ratio4.73 Perf Half Y1.80%
Book/sh10.45 P/B2.65 EPS next Y11.39% ROA4.90% Target Price32.89 Perf Year3.32%
Cash/sh0.03 P/C926.41 EPS next 5Y7.13% ROE11.50% 52W Range24.01 - 30.25 Perf YTD2.37%
Dividend1.66 P/FCF- EPS past 5Y-3.30% ROI7.80% 52W High-8.50% Beta0.90
Dividend %6.00% Quick Ratio0.60 Sales past 5Y-12.30% Gross Margin14.70% 52W Low15.29% ATR0.37
Employees6800 Current Ratio0.80 Sales Q/Q5.30% Oper. Margin15.60% RSI (14)48.60 Volatility1.19% 1.33%
OptionableYes Debt/Eq1.07 EPS Q/Q-49.30% Profit Margin10.90% Rel Volume0.79 Prev Close27.65
ShortableYes LT Debt/Eq0.96 EarningsMay 02 BMO Payout132.30% Avg Volume4.11M Price27.68
Recom1.60 SMA200.45% SMA50-0.63% SMA2001.69% Volume3,223,473 Change0.11%
Apr-18-17Initiated Guggenheim Buy
Jan-31-17Reiterated Barclays Overweight $31 → $33
Nov-16-16Initiated Ladenburg Thalmann Buy
Sep-30-16Initiated Mizuho Buy $32
Sep-19-16Upgrade Credit Suisse Neutral → Outperform
Aug-31-16Reiterated Wunderlich Buy $33 → $32
Aug-18-16Downgrade Morgan Stanley Overweight → Equal-Weight
May-11-16Initiated Bernstein Outperform $33
Apr-29-16Downgrade Seaport Global Securities Buy → Neutral $30
Jan-20-16Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-06-16Initiated Scotia Howard Weil Sector Outperform $31
Nov-03-15Reiterated Argus Buy $44 → $38
Jul-31-15Reiterated Stifel Buy $38 → $34
Jul-23-15Initiated DA Davidson Buy $36
Jun-16-15Initiated Sun Trust Rbsn Humphrey Buy
May-19-15Initiated Wunderlich Buy $38
May-19-15Initiated Deutsche Bank Buy $38
Jan-20-15Reiterated Oppenheimer Outperform $44 → $39
Jun-03-14Initiated Global Hunter Securities Buy $83
May-02-14Reiterated Stifel Buy $75 → $78
Apr-21-17 07:37AM  Kinder Morgans 1Q17 Net Income Falls 9%, Misses Estimates Market Realist
Apr-20-17 11:46AM  EnLink Midstream Partners Implied Volatility Rose the Most Market Realist
11:06AM  Better Buy: Enterprise Products Partners L.P. vs. Buckeye Partners, L.P. Motley Fool
07:36AM  What Does ONEOKs Current Valuation Indicate? Market Realist
Apr-18-17 05:05PM  How Williams Partners Expects to Benefit from Geismar Plant Sale Market Realist
10:37AM  What Does Kinder Morgans Valuation Indicate? Market Realist
Apr-17-17 08:15AM  Blog Coverage ConocoPhillips Nets $3 Billion from Sale of San Juan Basin Assets to Hilcorp Energy Accesswire
Apr-15-17 09:16AM  2 Top Dividend Stocks for Low-Risk Investors Motley Fool
Apr-13-17 11:08AM  Love Dividends? Here's 4 Energy Sector Stocks You Might Want to Buy Motley Fool
10:00AM  I Still Can't Believe Enterprise Products Partners L.P. Spent $189 million on This Bankrupt Company Motley Fool
Apr-12-17 01:23PM  Enterprise Products Partners LP Value Analysis (NYSE:EPD) : April 12, 2017 Capital Cube
08:58AM  Enterprise Sets Record for Volumes at Texas Gulf Coast Marine Terminals Business Wire
Apr-11-17 10:46AM  Enterprise to Build 571 Mile Pipeline from Permian Basin Zacks
10:11AM  2 Energy Stocks I'd Buy Right Now Motley Fool
08:20AM  Enterprise Products Partners LP breached its 50 day moving average in a Bullish Manner : EPD-US : April 11, 2017 Capital Cube
07:37AM  Is Enterprise Products Partners Fairly Valued? Market Realist
Apr-10-17 03:05PM  Analyzing Short Interest in Enterprise Products Partners Stock Market Realist
02:15PM  Enterprise Products Partners to build 571-mile NGL pipeline American City Business Journals
01:35PM  What to Expect from Enterprise Products Partners Stock Market Realist
12:00PM  Is Enterprise Products Partners Stock Gaining Strength? Market Realist
11:59AM  Enterprise Products Partners Raised Its 1Q17 Distribution Market Realist
08:30AM  Enterprise to Build Shin Oak NGL Pipeline from Permian Basin to Mont Belvieu, Texas Business Wire
Apr-08-17 12:00PM  Top Fracking Stocks to Buy in 2017 Motley Fool
Apr-07-17 02:39PM  Enterprise Products Partners: Look for a Resolution to the Upside TheStreet.com
07:24AM  In the midst of an oil-price slump, one area in Texas is enjoying a bit of a boom MarketWatch
Apr-06-17 02:36PM  MLPs with the Maximum Potential Upside after 1Q17 Market Realist
10:09AM  Enterprise Products Announces Quarterly Distribution Hike Zacks
08:24AM  3 Stocks We'd Buy and Hold for the Next 20 Years Motley Fool
06:26AM  [$$] Why the Texas natural gas boom is making waves Financial Times
Apr-05-17 08:51AM  Enterprise Declares Quarterly Distribution Increase Business Wire
Apr-04-17 04:20PM  Houston company to build ethylene storage, pipeline projects American City Business Journals
10:29AM  Enterprise Products Partners to Expand Ethylene Projects Zacks
07:37AM  Is ONEOK Stock Fairly Valued? Market Realist
Apr-03-17 02:33PM  These 6 Energy Names Are Big Holdings of the Most MLP Funds Barrons.com
12:05PM  Kinder Morgan Stock Gains Strength, but Can It Keep It Up? Market Realist
08:30AM  Enterprise to Develop Ethylene Storage and Transportation Projects Business Wire
Mar-31-17 12:14PM  5 Things You Didn't Know About Enterprise Products Partners L.P. Motley Fool
08:30AM  Enterprise Products Partners to Participate in Mizuho Energy Infrastructure Conference Business Wire
Mar-29-17 12:13PM  3 Top Dividend Stocks in Energy to Buy Now at Motley Fool
07:37AM  Analysts Recommendations for ONEOK
07:35AM  EPD: When Will the Oil Market Likely Balance?
Mar-28-17 06:00PM  The Wealthiest Oil & Gas Billionaires In The U.S.
02:36PM  ONEOK Is Trading near Its Historical Average
10:37AM  Analysts Recommendations for Enterprise Products Partners
09:05AM  What Does Short Interest in EPD Stock Indicate?
07:35AM  Are Institutional Investors Selling Their Holdings in EPD?
Mar-27-17 04:35PM  Is Kinder Morgans Current Valuation Attractive?
10:36AM  Analyzing Enterprise Products Partners Valuation
09:06AM  Why Enterprise Products Partners Leverage Isnt a Concern
07:37AM  Enterprise Products Partners Focuses on Petrochemicals
Mar-24-17 10:36AM  What Will Drive Enterprise Products Partners Growth?
09:29AM  Enterprise Products Partners to Participate in Scotia Howard Weil Energy Conference Business Wire
09:06AM  Retaining Cash Flows Helped Enterprise Products Partners
07:36AM  Why Enterprise Products Partners Focuses on Organic Growth
Mar-23-17 03:35PM  Enterprise Products Partners Increases Its NGL Export Volumes
02:05PM  Enterprise Products Partners: Key Player in US LPG Exports
12:33PM  Analyzing Enterprise Products Partners Business Segments
12:33PM  Enterprise Products Partners Extensive Asset Footprint
12:33PM  Whats Ahead for Enterprise Products Partners Stock?
Mar-22-17 07:37AM  What Does ONEOKs Current Valuation Indicate?
07:36AM  Is Kinder Morgan Attractively Valued?
Mar-21-17 10:41AM  Better Buy: Kinder Morgan, Inc. vs. Enterprise Products Partners L.P. at Motley Fool
10:24AM  Weakness in ONEOK Continues, Stock Fell 2.8% Last Week
08:36AM  The 3 Best Stocks to Profit From Low Interest Rates While They Last at Motley Fool
Mar-20-17 02:05PM  Why MLPs Continue to Be Attractive
Mar-18-17 10:32AM  Hate Risk? You'll Love These 2 Dividend Stocks at Motley Fool
08:10AM  Like Big Dividends? The I Bet You'll Love These 3 Stocks at Motley Fool
Mar-17-17 10:54AM  Enterprise Products Partners LP : EPD-US: Dividend Analysis : January 31st, 2017 (record date) : By the numbers : March 17, 2017
07:35AM  Is Enbridge Energy Partners Attractively Valued?
Mar-16-17 10:00AM  Can This 10% Dividend Even Survive? at Motley Fool
09:35AM  Houston energy co. wins midstream assets in bankruptcy auction at bizjournals.com
Mar-15-17 03:43PM  [$$] Enterprise Products Partners Buying Assets of Azure Midstream at The Wall Street Journal
01:36PM  Enterprise Acquires Azure Natural Gas Gathering System Business Wire
08:31AM  The 5 Best Dividend Stocks of 2027 at Motley Fool
Mar-14-17 03:32PM  Top Natural Gas Stocks to Buy in 2017 at Motley Fool
09:07AM  Is Williams Companies Currently Undervalued?
Mar-13-17 04:22PM  [$$] Azure Midstream's Assets Fetch $189 Million at Auction at The Wall Street Journal
11:25AM  Enterprise Products Partners Favored by Analysts at Investopedia
10:37AM  A Look at MLPs with an Attractive Potential Upside
Mar-10-17 05:07PM  Are MLPs Still Undervalued?
04:23PM  Better Pipeline Dividend Stock Buy: Kinder Morgan or Enterprise Products?
Mar-09-17 09:44AM  4 High-Yield Dividend Stocks You Don't Have to Babysit at Motley Fool
07:24AM  Enterprise (EPD) Closes Seaway Pipeline After Potential Leak
Mar-07-17 04:35PM  What Williams Companies Current Valuation Indicates
10:42AM  Which Midstream Stocks Have the Highest Implied Volatility?
09:20AM  3 Energy Stocks We Can't Help but Love at Motley Fool
08:00AM  Enterprise Products Partners to Host Analyst Day Business Wire
Mar-06-17 03:41PM  Enterprise Products Partners' Seaway pipeline shut after leak -traders
11:23AM  Enterprise Products Partners' Seaway pipeline shut after leak: traders
Mar-02-17 01:04PM  ENTERPRISE PRODUCTS PARTNERS L P Financials
07:38AM  What Analysts Recommend for ONEOK after 4Q16 Results
Mar-01-17 12:39PM  ONEOKs 4Q16 Earnings: Effect of Natural Gas, NGL Volumes
Feb-27-17 08:00AM  Enterprise Products Partners to Participate in Investor Conferences Business Wire
Feb-24-17 01:10PM  2016 K-1 Tax Packages for Enterprise Products Partners L.P. Business Wire
11:05AM  ENTERPRISE PRODUCTS PARTNERS L P Files SEC form 10-K, Annual Report
10:09AM  Enterprise Products Partners L.P. 2016 Form 10-K Now Available Business Wire
Feb-23-17 04:15PM  Enterprise Signs Natural Gas Processing Agreements with Producers from Wyomings Green River Basin Business Wire
10:41AM  Energy Transfer says Dakota Access pipeline 99 pct complete Reuters
Feb-22-17 10:06AM  3 Value Stocks Senior Citizens Could Buy Right Now at Motley Fool
09:06AM  79% of Analysts Recommend a Hold for ONEOK
Enterprise Products Partners L.P. provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products. The company operates through NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services segments. The NGL Pipelines & Services segment offers natural gas processing and related NGL marketing services, as well as NGL export docks and related services. It operates approximately 19,670 miles of NGL pipelines; NGL and related product storage facilities; 15 NGL fractionators; and a liquefied petroleum gas and ethane export terminals, and related operations. The Crude Oil Pipelines & Services segment operates approximately 5,400 miles of crude oil pipelines and related operations; and crude oil storage and marine terminals located in Oklahoma and Texas, as well as a fleet of 440 tractor-trailer tank trucks used to transport crude oil. It also engages in crude oil marketing activities. The Natural Gas Pipelines & Services segment operates approximately 19,120 miles of natural gas pipeline systems to gather and transport natural gas in Colorado, Louisiana, New Mexico, Texas, and Wyoming. It leases underground salt dome natural gas storage facilities in Texas and Louisiana; owns an underground salt dome storage cavern in Texas; and markets natural gas. The Petrochemical & Refined Products Services segment operates propylene fractionation and related operations, including 686 miles of pipelines; butane isomerization complex, associated deisobutanizer units, and related pipeline assets; and octane enhancement and high purity isobutylene production facilities. It also operates approximately 4,250 miles of refined products pipelines; and terminals, as well as provides refined products marketing and marine transportation services. The company was founded in 1968 and is based in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smith Edwin EAdvisory DirectorMar 06Sale28.0215,000420,300420,654Mar 06 05:18 PM
HACKETT JAMES TDirectorFeb 03Buy28.6533,000945,45033,000Feb 06 04:14 PM
BARTH CARIN MARCYDirectorNov 16Buy25.274,000101,08013,126Nov 16 04:50 PM
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-3.12 Insider Own0.20% Shs Outstand356.40M Perf Week-0.62%
Market Cap84.24B Forward P/E13.20 EPS next Y17.91 Insider Trans-8.22% Shs Float334.81M Perf Month1.01%
Income-1219.50M PEG- EPS next Q3.32 Inst Own93.00% Short Float3.37% Perf Quarter10.58%
Sales14.57B P/S5.78 EPS this Y63.30% Inst Trans0.03% Short Ratio3.78 Perf Half Y3.54%
Book/sh199.95 P/B1.18 EPS next Y11.71% ROA10.90% Target Price268.67 Perf Year4.19%
Cash/sh37.11 P/C6.37 EPS next 5Y13.90% ROE19.60% 52W Range183.98 - 260.53 Perf YTD12.86%
Dividend2.80 P/FCF103.55 EPS past 5Y-28.70% ROI0.10% 52W High-9.28% Beta1.16
Dividend %1.18% Quick Ratio2.20 Sales past 5Y26.00% Gross Margin87.20% 52W Low28.47% ATR2.97
Employees16700 Current Ratio2.30 Sales Q/Q7.10% Oper. Margin-12.50% RSI (14)42.79 Volatility1.13% 1.29%
OptionableYes Debt/Eq0.47 EPS Q/Q85.60% Profit Margin- Rel Volume0.57 Prev Close237.94
ShortableYes LT Debt/Eq0.42 EarningsMay 09 BMO Payout0.00% Avg Volume2.98M Price236.35
Recom2.00 SMA20-0.76% SMA50-1.90% SMA2003.56% Volume1,713,925 Change-0.67%
Feb-09-17Reiterated Mizuho Buy $273 → $275
Dec-09-16Reiterated Credit Suisse Outperform $301 → $274
Nov-17-16Reiterated Mizuho Buy $293 → $273
Nov-03-16Reiterated RBC Capital Mkts Outperform $300 → $279
Nov-01-16Reiterated Mizuho Buy $299 → $293
Oct-31-16Resumed Barclays Equal Weight $250
Oct-11-16Reiterated Mizuho Buy $305 → $299
Aug-19-16Upgrade Mizuho Neutral → Buy $248 → $318
Aug-09-16Reiterated RBC Capital Mkts Outperform $307 → $300
Aug-09-16Reiterated Deutsche Bank Buy $282 → $278
Aug-05-16Reiterated Mizuho Neutral $232 → $246
Jul-27-16Reiterated Leerink Partners Outperform $272 → $294
Jul-25-16Initiated Credit Suisse Outperform $327
May-13-16Reiterated Mizuho Neutral $250 → $232
Apr-18-16Resumed Goldman Buy $275
Apr-18-16Initiated Guggenheim Neutral
Apr-18-16Downgrade Piper Jaffray Overweight → Neutral $311 → $238
Apr-07-16Resumed Morgan Stanley Overweight $300
Apr-07-16Resumed JP Morgan Overweight
Apr-07-16Reiterated UBS Buy $366 → $300
Apr-24-17 01:00AM  NASH: The next untapped pharma market gives investors many options Reuters
Apr-23-17 05:30PM  Trump Executive Order Could Revive Allergan-Pfizer Merger TheStreet.com
11:41AM  Should Gilead Sciences Be Worried About Allergan? Motley Fool
Apr-21-17 03:28PM  Charlie Munger: Loading Up on Leverage GuruFocus.com
09:00AM  Top Analyst Upgrades and Downgrades: Costco, Dominos Pizza, Fortinet, Verizon, Yum Brands and More 24/7 Wall St.
07:12AM  Pharma Stock Roundup: J&J Slips on Mixed Q1, Lilly Hit by FDA CRL Zacks
Apr-20-17 04:15PM  Allergan Announces 13 Presentations on Chronic Migraine, Upper and Lower Limb Spasticity, Cervical Dystonia and Alzheimer's Disease at the American Academy of Neurology Meeting in Boston PR Newswire
02:15PM  Chapel Hill company partners with Allergan American City Business Journals
09:00AM  Allergan Partners with TARGET PharmaSolutions to Advance NASH Research PR Newswire
Apr-19-17 10:11AM  Allergan (AGN) Collaborates with Novartis to Treat NASH Zacks
07:00AM  [$$] Investors bet on Incyte drug success Financial Times
Apr-18-17 04:51PM  Allergan, Argentum settle patent dispute over eye drug Restasis Reuters
01:15AM  Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration PR Newswire
Apr-17-17 06:33AM  A Healthcare Pick That's Moderately Shielded From Upheaval Morningstar
Apr-13-17 03:40PM  Why Charlie Munger Hates Value Investing GuruFocus.com
09:00AM  Allergan and Ironwood Launch Campaign Designed to Empower the Nearly 64 Million Americans Estimated to Suffer from IBS and CIC to Talk About Bowel Health(1-5) PR Newswire
Apr-12-17 06:03AM  The Real Trump Trade May Be Gold: Cramer's 'Mad Money' Recap (Tuesday 4/11/17) TheStreet.com
Apr-11-17 07:12PM  Cramer Remix: Why a slew of IPOs might not be a good thin... CNBC Videos
06:53PM  Cramer's charts show these biotechs ignoring their 'polit... CNBC Videos
07:30AM  Allergan Launches Frames of Mind, Encouraging People Living with Migraine to Share Common Experiences Through Art PR Newswire
Apr-10-17 10:36AM  How Did Allergan Perform in 1Q17? Market Realist
09:00AM  Allergan Receives 2017 ENERGY STAR® Partner of the Year - Sustained Excellence Award from U.S. Environmental Protection Agency PR Newswire
01:00AM  Takeaways and Observations; Play a Tesla Tune: Doug Kass' Views TheStreet.com
Apr-09-17 03:55PM  Valeant: It's Not a Game of Chess - Part IV GuruFocus.com
Apr-08-17 11:30AM  Allergan is still hopeful about using Botox to treat depression MarketWatch
Apr-07-17 11:00AM  Allergan Teams Up With Media Mogul Wendy Williams to Debut the Patient Empowerment Campaign - Toilet Talk PR Newswire
10:24AM  3 Stocks the Smartest Investors Are Buying Right Now Motley Fool
08:47AM  5 Drug Stocks for Your Portfolio this World Health Day Zacks
Apr-06-17 04:15PM  Allergan Names Daphne Karydas as Senior Vice President of Global Investor Relations & Strategy PR Newswire
01:35PM  Allergan Guilty of Wishful Botox Thinking Bloomberg
11:30AM  Allergan's Botox Studied as Depression Treatment Investopedia
11:29AM  [$$] Investors question Allergan move to test Botox for depression Financial Times
11:18AM  Allergan (AGN) Presents Mixed Depression Data on Botox Zacks
08:31AM  Allergan Plc breached its 50 day moving average in a Bearish Manner : AGN-US : April 6, 2017 Capital Cube
08:22AM  Novartis Licenses ECF843 Eye Drops From Lubris Investopedia
08:00AM  Allergan and ZELTIQ Announce Expiration of Hart-Scott-Rodino Waiting Period for Pending Transaction PR Newswire
Apr-05-17 05:30PM  Allergan to move Botox into late-stage testing for depression Reuters
04:30PM  Allergan Reports Topline Phase II Data Supporting Advancement of BOTOX® (onabotulinumtoxinA) for the Treatment of Major Depressive Disorder (MDD) PR Newswire
04:18PM  Allergan To Test Botox For Depression Despite Mixed Results Forbes
08:00AM  Allergan to Report First Quarter 2017 Earnings and Host Conference Call and Webcast PR Newswire
02:46AM  Why Is Allergan (AGN) Down 2.2% Since the Last Earnings Report? Zacks
Apr-04-17 12:20PM  Paratek shares soar as antibiotic passes late-stage hurdle American City Business Journals
11:14AM  Why Paratek Pharmaceuticals Inc Is Soaring Motley Fool
Mar-31-17 10:36AM  Exploring Eli Lillys Oncology Franchise in 2016
07:21AM  Pharma Stock Roundup: FDA Nod for SNY, Roche Drugs, Generic Advair Relief for GSK? Zacks
07:00AM  Healthcare: Stock-Picking Increasingly Important as Valuations Rise Morningstar
Mar-30-17 11:45AM  Why Equal Weighted Mutual Funds Scoring Over Index Funds Investopedia
07:27AM  Bill Ackman apologizes for $4 billion Valeant mistake (finally) at MarketWatch
Mar-29-17 06:25PM  Bill Ackman's Insider Trading Lawsuit May Cost Pershing Square Investors $75 Million
05:40PM  Fast Money Madness: Nvidia vs. Allergan
03:47PM  Here's the Bill Ackman apology Wall Street's been waiting for
07:00AM  Market Outlook: Lofty Valuations Call for Careful Stock-Picking at Morningstar
Mar-28-17 04:30PM  Did This Beauty Giant Just Solve The Acne Challenge?
04:09PM  2016s Top Earning Hedge Fund Managers And Their Favorite Stocks at Insider Monkey
11:47AM  Allergan Acne Candidate Meets Endpoints in Phase III Studies
08:15AM  Blog Coverage Allergan and Paratek's Acne Drug Reported Positive Results Accesswire
Mar-27-17 07:00PM  Risk-Reward With Teva Pharmaceutical
06:00PM  Why Impax Labs Soared 37.3% Today at Motley Fool
05:46PM  Health care showdown: Allergan vs. Valeant
05:05PM  DuPont, Impax Labs gain, G-III Apparel slides
01:20PM  Has Allergan's Pullback Ended?
12:41PM  Why Moat Indexes Outperformed Others in February
11:34AM  Allergan, Parateks Acne Drug Succeeds in Phase 3 at Investopedia
11:20AM  Paratek eyes FDA filing as acne drug clears late-stage trials at bizjournals.com
11:20AM  Foamix Acne Drug Fails Late-Stage Study at Investopedia
09:28AM  Skincare Makers Lead Biotech Movers
07:48AM  Allergan, Paratek Pharma report positive results in late-stage trial of acne treatment at MarketWatch
07:36AM  Vyzulta May Be a Potent Therapy for Glaucoma in the Future
07:31AM  Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline for the Treatment of Moderate to Severe Acne PR Newswire
07:30AM  Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline for the Treatment of Moderate to Severe Acne GlobeNewswire
Mar-26-17 11:01AM  3 Great Stocks to Buy in a Market Pullback at Motley Fool
Mar-24-17 02:00PM  Can Anyone Challenge Allergan In Medical-Aesthetics Market?
07:35AM  Valeant Pharmaceuticals is Developing its Sales Force
01:00AM  After Trump rally, equity investors move into healthcare, retailers Reuters
Mar-23-17 06:31PM  The Most Attractive Value Stock There Is?
11:24AM  Insys Therapeutics' Syndros Gets Final DEA Rule at Investopedia
10:19AM  Allergan's Restasis Now Available in Multidose Bottle in U.S.
09:20AM  Buyback ETF Steady As Repurchases Decline
09:06AM  Teva Denies Reports About 11% Global Workforce Reduction (TEVA) at Investopedia
08:59AM  The Supreme Court could fundamentally change America's broken patent system
Mar-22-17 06:45PM  Companies Spend Less on Share Buybacks for Second Year in 2016
04:35PM  Allergan, Dow's Apple Lead Q4 Buybacks; Health Care Atop S&P 500
02:52PM  Allergan Stock Reacts Well In Downtrodden Sector at Investopedia
10:30AM  Latest Editas research pact could be worth up to $1 billion at bizjournals.com
07:31AM  Allergan Announces Availability of RESTASIS MULTIDOSE (Cyclosporine Ophthalmic Emulsion) 0.05% -- the First FDA-Approved Preservative Free Prescription Eye Drop Available in a Multidose Bottle PR Newswire
Mar-21-17 05:35PM  David Tepper Takes Big Risks for Big Rewards
05:26PM  FDA Links Breast Implants To A Rare Form Of Cancer
02:58PM  Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod
Mar-20-17 04:51PM  Editas Get A Vetr Upgrade To Strong Buy
01:53PM  Allergan Is Setting Up Nicely for a Possible Move at Investopedia
07:31AM  JUVÉDERM VOLLURE XC Approved by U.S. FDA for Correction of Facial Wrinkles and Folds in Adults over the Age of 21 PR Newswire
Mar-17-17 09:27AM  Pharma Stock Roundup: AstraZeneca's Lynparza Impresses in Study, Merck Drug Label Expanded
Mar-16-17 03:36PM  Valeant: Yes, Ackman's a Loser. But How Much Did Short Sellers Make? at Barrons.com
12:35PM  Court allows Allergan shareholders to go after Ackman, Valeant as a class at bizjournals.com
06:11AM  When Very Predictable Is Highly Profitable: Cramer's 'Mad Money' Recap (Wednesday 3/15/17)
Mar-15-17 07:15PM  How to maneuver CEO buybacks
06:53PM  Cramer on how investors should maneuver CEO buybacks
06:35PM  Cramer on how investors should maneuver amid CEO buybacks at CNBC
05:46PM  Allergan (AGN) and Editas Tie Up to Treat Eye Diseases
10:37AM  David Tepper on Allergan: Does It Look Cheap?
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Specialized Therapeutics, US General Medicine, and International segments. The company offers a portfolio of products that provide treatment for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, dermatology, plastic surgery, liver disease, inflammation, metabolic syndromes, and fibrosis, as well as Alzheimer's disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, the company distributes generic and branded pharmaceutical products primarily to independent and chain pharmacies, nursing homes, mail order pharmacies, hospitals, clinics, and physician offices. Further, it develops a portfolio of breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. The company has licensing agreement with Assembly Biosciences, Inc.; Mimetogen Pharmaceuticals, Inc.; Almirall, S.A; Naurex, Inc.; and Merck & Co. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BISARO PAULDirectorMar 02Sale246.6870,00017,267,561235,900Mar 06 06:59 AM
Meury WilliamChief Commercial OfficerDec 08Option Exercise109.1211,8071,288,38048,866Feb 14 09:13 PM
Basgoz NesliDirectorDec 08Sale188.7250094,3605,515Dec 09 05:56 PM
SAUNDERS BRENT LCEO and PresidentNov 21Buy189.135,250992,941106,564Nov 21 04:03 PM
Hilado Maria TeresaChief Financial OfficerNov 11Buy210.641,422299,53613,379Nov 15 05:18 PM
NSC Norfolk Southern Corporation daily Stock Chart
NSC [NYSE]
Norfolk Southern Corporation
IndexS&P 500 P/E20.85 EPS (ttm)5.58 Insider Own0.10% Shs Outstand301.94M Perf Week4.29%
Market Cap35.14B Forward P/E16.82 EPS next Y6.92 Insider Trans-26.60% Shs Float301.94M Perf Month4.12%
Income1.66B PEG1.77 EPS next Q1.36 Inst Own66.20% Short Float1.14% Perf Quarter2.98%
Sales9.89B P/S3.55 EPS this Y10.30% Inst Trans-0.54% Short Ratio1.69 Perf Half Y23.10%
Book/sh41.71 P/B2.79 EPS next Y11.45% ROA4.80% Target Price121.78 Perf Year44.40%
Cash/sh3.17 P/C36.75 EPS next 5Y11.78% ROE13.50% 52W Range77.30 - 125.00 Perf YTD8.24%
Dividend2.44 P/FCF77.74 EPS past 5Y0.60% ROI9.50% 52W High-6.90% Beta1.37
Dividend %2.10% Quick Ratio0.90 Sales past 5Y-2.40% Gross Margin44.60% 52W Low50.55% ATR2.28
Employees28044 Current Ratio1.00 Sales Q/Q-1.10% Oper. Margin31.10% RSI (14)54.75 Volatility1.63% 1.85%
OptionableYes Debt/Eq0.82 EPS Q/Q15.70% Profit Margin16.80% Rel Volume1.01 Prev Close115.81
ShortableYes LT Debt/Eq0.77 EarningsApr 26 BMO Payout41.90% Avg Volume2.04M Price116.37
Recom2.60 SMA202.58% SMA50-0.84% SMA20012.89% Volume2,073,025 Change0.48%
Mar-23-17Downgrade RBC Capital Mkts Sector Perform → Underperform $113
Mar-14-17Initiated Wells Fargo Outperform
Jan-26-17Reiterated Cowen Outperform $116 → $130
Jan-18-17Initiated Buckingham Research Neutral
Jan-10-17Downgrade CLSA Outperform → Underperform
Jan-09-17Downgrade Seaport Global Securities Buy → Neutral $101 → $106
Nov-02-16Upgrade Argus Hold → Buy
Nov-02-16Initiated Deutsche Bank Buy $110
Oct-11-16Upgrade BofA/Merrill Neutral → Buy
Jun-03-16Resumed Morgan Stanley Underweight
May-19-16Initiated Credit Agricole Outperform
Apr-25-16Resumed JP Morgan Neutral
Apr-22-16Upgrade UBS Neutral → Buy $84 → $102
Apr-22-16Upgrade Credit Suisse Neutral → Outperform
Apr-22-16Reiterated Cowen Outperform $89 → $101
Apr-22-16Reiterated Barclays Equal Weight $88 → $90
Apr-13-16Resumed BofA/Merrill Neutral
Jan-28-16Upgrade Avondale Mkt Underperform → Mkt Perform
Jan-28-16Reiterated RBC Capital Mkts Sector Perform $84 → $74
Jan-28-16Reiterated Cowen Outperform $93 → $89
Apr-21-17 02:35PM  Norfolk Southern: Trailers Rise by Double Digits in Week 15 Market Realist
01:05PM  Norfolk Southern: Commodities That Fueled Volumes in Week 15 Market Realist
12:54PM  Can Railroads Prosper Under the Trump Administration? Zacks
09:47AM  Will Norfolk Southern (NSC) Deliver a Beat in Q1 Earnings? Zacks
Apr-20-17 05:03PM  Inside Union Pacifics Stock Performance Ahead of Its 1Q17 Earnings Market Realist
12:53PM  Norfolk Southern's Breakout Could Be Derailed TheStreet.com
09:07AM  Norfolk Southern on the Street: Why Analysts Say Hold before the 1Q17 Results Market Realist
07:37AM  Norfolk Southerns Earnings: Against the Estimates for 1Q17 Market Realist
Apr-19-17 12:35PM  Inside Norfolk Southerns Efficiency Drive: Operating Margins Now Market Realist
11:05AM  Can Norfolk Southern Beat Analysts 1Q17 Revenue Estimates? Market Realist
10:31AM  Zacks Industry Outlook Highlights: CSX, Canadian Pacific Railway, Norfolk Southern, Union Pacific and Kansas City Southern Zacks
09:29AM  Why a Norfolk Southern 1Q17 Earnings Preview Matters Market Realist
Apr-18-17 05:35PM  Intermodal Traffic for Norfolk Southern in Week 14 of 2017 Market Realist
04:58PM  Railroad Stock Industry Outlook - April 2017 Zacks
04:05PM  Norfolk Southern: What Drove Freight Volumes in Week 14? Market Realist
Apr-11-17 09:07AM  CSXs Freight Volumes: How It Stacked Up against Its Peers Market Realist
07:37AM  Norfolk Southern: Chasing Its Intermodal Volumes in Week 13 of 2017 Market Realist
Apr-10-17 05:05PM  Norfolk Southern: Why Freight Volumes Rose in Week 13 of 2017 Market Realist
11:30AM  Norfolk Southern awards 55 chemical customers for safe rail-shipping practices PR Newswire
Apr-07-17 03:49PM  Pro on automation: Zero correlation between eliminating j... CNBC Videos
Apr-05-17 10:26AM  Coking Coal Prices Surge Following Australian Cyclone Damage -- Jim Cramer Weighs In TheStreet.com
10:26AM  Coking Coal Prices Surge Following Australian Cyclone Damage -- Jim Cramer Weighs In
Apr-04-17 09:06AM  Solid Growth in Volumes without Coal Raises CNIs Carloads Market Realist
09:06AM  Solid Growth in Volumes without Coal Raises CNIs Carloads
Apr-03-17 04:05PM  Norfolk Southern to hold first-quarter 2017 earnings conference call April 26 PR Newswire
09:07AM  How CSXs Carloads Fared against Norfolk Southern in Week 12 Market Realist
09:07AM  How CSXs Carloads Fared against Norfolk Southern in Week 12
07:37AM  What Drove Norfolk Southerns Intermodal Traffic in Week 12 Market Realist
07:37AM  What Drove Norfolk Southerns Intermodal Traffic in Week 12
Mar-31-17 05:35PM  Unloading Norfolk Southerns Carloads in Week 12 Market Realist
05:35PM  Unloading Norfolk Southerns Carloads in Week 12
12:00PM  Profiting off Trump's plan to rebuild America CNBC Videos
12:00PM  Profiting off Trump's plan to rebuild America
07:37AM  What the February Truck Tonnage Index Suggests Market Realist
07:37AM  What the February Truck Tonnage Index Suggests
Mar-30-17 05:08PM  What Infrastructure Spending Cuts Mean for Freight Companies Market Realist
05:08PM  What Infrastructure Spending Cuts Mean for Freight Companies
Mar-29-17 09:06AM  Why Canadian Nationals Carload Growth Outpaced Its Class I Peers
07:37AM  Comparing CSXs Carload Changes with Rival Norfolk Southerns
07:03AM  Looking to buy the dip? Check out these beaten-down secto...
Mar-28-17 03:35PM  Behind Norfolk Southerns Intermodal Volumes in Week 11
02:05PM  How Norfolk Southerns Carloads Stacked Up in Week 11
12:11PM  US Freight Rail Traffic in the Green, Canada and Mexico Follow
10:10AM  NORFOLK SOUTHERN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc. o
Mar-23-17 09:55AM  Cramer's Stop Trading: Love affair with rails running out...
09:05AM  How Did GWRs North American Carloads Trend in February 2017?
Mar-22-17 08:05AM  Norfolk Southern's 2016 Annual Report highlights commitments met to lower costs, increase profitability, improve service, and enhance shareholder value PR Newswire
07:36AM  Canadian Nationals Carload Growth Is Faster than Peer Average
Mar-21-17 09:07AM  Is NSCs Intermodal Volume Growth Keeping Pace with Peers?
07:37AM  How Norfolk Southerns Carloads Stacked Up against Peers
Mar-20-17 05:00PM  US and Canada Freight Rail Traffic Volumes Were in the Fast Lane
02:20PM  Norfolk Southern safety train begins 23-city tour to educate first responders PR Newswire
10:51AM  Norfolk Southern Corp. : NSC-US: Dividend Analysis : February 03rd, 2017 (record date) : By the numbers : March 20, 2017
Mar-16-17 09:06AM  Despite Coal Downfall, Canadian Nationals Carloads Kept Soaring
Mar-15-17 05:43PM  Rebounding Coal Bodes Well for Railroads: Here's Why
10:38AM  How Were CSXs Carload Volumes in Week Ended March 4?
09:15AM  For an Inflation Hedge, Jump Aboard This Railroad Monopoly
09:06AM  How Norfolk Southerns Intermodal Volumes Compare to Peers
07:37AM  These Commodities Boosted Norfolk Southerns Carloads
Mar-14-17 05:10PM  Which Rail Stock Should You Board? Breaking Down Wells Fargo's Initiations In The Sector
03:35PM  Northeast storm hits transport stocks
11:57AM  A Strategy That Beat the Bull Market
10:05AM  Analysts Chime in on Corning, Quest Diagnostics, Canadian Pacific, Norfolk Southern, and More at Insider Monkey
06:12AM  Coverage initiated on Norfolk Southern by Wells Fargo
Mar-13-17 06:00AM  An Ideal Investment for Long-Term Investors at Morningstar
Mar-09-17 06:17PM  CSX's new CEO eyes yard closures, truckers' market share Reuters
01:27PM  New CSX CEO eyes yard closures, truckers' market share to lift profits Reuters
Mar-08-17 04:55PM  Timothy Tierney named president and chief operating officer of Conrail PR Newswire
Mar-07-17 11:02AM  [$$] Miss the CSX Rally? Try Norfolk Southern at Barrons.com
10:36AM  This Drove Canadian Nationals Upward Momentum in Carloads
09:07AM  A Birds Eye View of CSXs Intermodal Volumes in the 8th Week
07:37AM  What Happened to CSXs Carloads in the 8th Week?
Mar-06-17 06:47PM  CSX reaches deal with hedge fund, hires new railroad CEO
04:05PM  Behind Norfolk Southerns Intermodal Volumes in the 8th Week
02:35PM  Where Norfolk Southerns Carloads Stand in the Industry Now
12:45PM  Canada and US Freight Rail Traffic Pulls ahead of Mexico
Feb-28-17 10:37AM  Looking at CSXs Intermodal Volumes in the 7th Week of 2017
09:08AM  Why Did CSXs Carloads Rise?
07:38AM  Comparing Norfolk Southerns Intermodal Volumes
Feb-27-17 05:35PM  Which Commodity Groups Boosted Norfolk Southerns Carloads?
Feb-22-17 09:06AM  Inside GWRs European Carload Rise in January
Feb-21-17 03:35PM  Inside Norfolk Southerns Intermodal Volumes in the 6th Week
02:06PM  How Higher Coal Volumes Are Lifting Up Norfolk Southern
Feb-16-17 04:15PM  Norfolk Southern to present at Barclays Industrial Select Conference PR Newswire
01:10PM  Is CSX Corporation Stock Gearing Up for Another Huge Year After a Fantastic 2016? at Motley Fool
Feb-15-17 07:00AM  Norfolk Southern's Wide Moat Remains on the Rails at Morningstar
Feb-14-17 11:38PM  CSX railroad wants shareholder vote on hedge fund's demands
02:00PM  Norfolk Southern opens new locomotive maintenance and repair shop in Chicago PR Newswire
Feb-13-17 10:36AM  Why Genesee and Wyomings European Revenue Fell in 4Q16
Feb-09-17 01:04PM  NORFOLK SOUTHERN CORP Financials
Feb-07-17 07:36AM  Why Did Norfolk Southerns Intermodal Volumes Rise?
Feb-06-17 06:06PM  Coal Volume Boosts Norfolk Southerns Carloads
04:05PM  Norfolk Southern to present at Stifel 2017 Transportation and Logistics Conference PR Newswire
12:33PM  NORFOLK SOUTHERN CORP Files SEC form 10-K, Annual Report
Feb-02-17 08:15AM  Post Earnings Coverage as Norfolk Southern's Q4 EPS Rose 18%; Beat Estimates Accesswire
Feb-01-17 08:15AM  Post Earnings Coverage as Kansas City Southern's Reported Q4 Results Accesswire
07:36AM  Which Commodities Boosted Canadian Nationals Carloads?
Jan-31-17 07:38AM  How Do Norfolk Southerns Intermodal Volumes Compare?
Jan-30-17 05:06PM  Why Norfolk Southerns Carloads Increased
09:06AM  Norfolk Southerns Recommendations: Why All the Holds?
Norfolk Southern Corporation, together with its subsidiaries, engages in the rail transportation of raw materials, intermediate products, and finished goods in the United States. It also transports overseas freight through various Atlantic and Gulf Coast ports. In addition, the company is involved in the operation of scheduled passenger trains; leasing or sale of rail property and equipment; development of commercial real estate; telecommunications; and the acquisition, leasing, and management of coal, oil, gas, and minerals, as well as the transport of automotive and industrial products. As of February 14, 2017, it operated approximately 19,500 route miles in 22 states and the District of Columbia. The company was founded in 1883 and is based in Norfolk, Virginia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STEWART MARTA REVP-Finance and CFOFeb 21Sale124.432,331290,04616,156Feb 23 08:02 AM
Hurlbut Thomas EVice President and ControllerFeb 17Option Exercise56.182,836159,3189,877Feb 21 01:46 PM
Hurlbut Thomas EVice President and ControllerFeb 17Sale122.371,475180,4907,100Feb 21 01:46 PM
STEWART MARTA REVP-Finance and CFOFeb 13Option Exercise75.142,370178,08220,857Feb 15 01:52 PM
STEWART MARTA REVP-Finance and CFOFeb 13Sale123.072,370291,67618,487Feb 15 01:52 PM
STEWART MARTA REVP-Finance and CFOFeb 09Option Exercise62.752,607163,57621,094Feb 10 10:57 AM
STEWART MARTA REVP-Finance and CFOFeb 09Sale121.972,607317,97618,487Feb 10 10:57 AM
Galanko William AndrewSVP - Law and Corp. Comm.Feb 06Option Exercise47.765,000238,80023,107Feb 08 09:02 AM
Galanko William AndrewSVP - Law and Corp. Comm.Feb 06Sale119.135,934706,91716,337Feb 08 09:02 AM
STEWART MARTA REVP-Finance and CFOFeb 03Option Exercise47.762,907138,83821,394Feb 06 03:34 PM
Hurlbut Thomas EVice President and ControllerFeb 03Sale120.651,297156,4777,041Feb 06 03:34 PM
STEWART MARTA REVP-Finance and CFOFeb 03Sale120.502,907350,29418,487Feb 06 03:34 PM
BOWLES ERSKINE BDirectorFeb 02Sale119.120133,475Feb 06 03:34 PM
CARP DANIEL ADirectorFeb 02Sale119.120533,886Feb 06 03:34 PM
LOCKHART MICHAEL DDirectorFeb 02Sale119.120193,729Feb 06 03:34 PM
THOMPSON JOHN RDirectorFeb 02Sale119.120163,144Feb 06 03:34 PM
BUSH WESLEY GDirectorFeb 02Sale119.1211183,387Feb 07 11:36 AM
Hurlbut Thomas EVice President and ControllerFeb 01Option Exercise47.7660728,9908,945Feb 03 05:17 PM
Hurlbut Thomas EVice President and ControllerFeb 01Sale118.2660771,7848,338Feb 03 05:17 PM
Squires James AChairman, President and CEOJan 26Option Exercise35.6037,4171,332,11095,709Jan 30 04:30 PM
STEWART MARTA REVP-Finance and CFOJan 26Option Exercise0.00950020,898Jan 30 04:32 PM
Wheeler Michael JosephEVP & Chief Operating OfficerJan 26Option Exercise0.00950012,046Jan 30 04:32 PM
Earhart Cynthia CExec. VP - Admin. and CIOJan 26Option Exercise0.0095005,813Jan 30 04:30 PM
Galanko William AndrewSVP - Law and Corp. Comm.Jan 26Option Exercise0.00950018,848Jan 30 04:30 PM
Hurlbut Thomas EVice President and ControllerJan 26Option Exercise0.0095009,083Jan 30 04:30 PM
Shaw Alan H.EVP & Chief Marketing OfficerJan 26Option Exercise0.0055004,264Jan 30 04:30 PM
Squires James AChairman, President and CEOJan 26Sale119.7734,4174,122,29354,589Jan 30 04:30 PM
Hurlbut Thomas EVice President and ControllerNov 18Sale103.7746948,6677,041Nov 21 03:03 PM
Shaw Alan H.EVP & Chief Marketing OfficerNov 16Option Exercise47.762,700128,9524,759Nov 18 03:30 PM
Shaw Alan H.EVP & Chief Marketing OfficerNov 16Sale103.171,654170,6402,622Nov 18 03:30 PM
Squires James AChairman, President and CEONov 11Option Exercise42.764,676199,93749,643Nov 14 10:41 AM
STEWART MARTA REVP-Finance and CFONov 11Sale100.901,970198,7739,774Nov 14 10:15 AM
STEWART MARTA REVP-Finance and CFONov 10Sale100.082,017201,86111,744Nov 14 10:15 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsNov 09Option Exercise38.7114,417558,010136,234Nov 10 09:45 AM
Earhart Cynthia CExec. VP - Admin. and CIONov 09Option Exercise38.714,417170,9604,417Nov 10 09:58 AM
Earhart Cynthia CExec. VP - Admin. and CIONov 09Sale99.004,417437,2980Nov 10 09:58 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsNov 09Sale97.0014,4171,398,449121,817Nov 10 09:45 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsNov 08Option Exercise38.7110,000387,050142,647Nov 10 09:45 AM
Earhart Cynthia CExec. VP - Admin. and CIONov 08Option Exercise50.744,530229,8524,530Nov 10 09:58 AM
Earhart Cynthia CExec. VP - Admin. and CIONov 08Sale96.184,530435,6730Nov 10 09:58 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsNov 08Sale95.4820,8301,988,850121,817Nov 10 09:45 AM
STEWART MARTA REVP-Finance and CFONov 07Sale94.102,023190,3647,824Nov 08 03:43 PM
Hurlbut Thomas EVice President and ControllerNov 07Sale94.461,00094,4617,560Nov 08 03:44 PM
Hurlbut Thomas EVice President and ControllerOct 27Sale91.212,170197,9208,560Oct 28 04:43 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsOct 03Option Exercise59.785,016299,851132,647Oct 04 04:26 PM
STEWART MARTA REVP-Finance and CFOSep 19Option Exercise75.141,33099,93612,127Sep 20 01:58 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsAug 30Option Exercise38.718,557331,199136,188Aug 31 11:43 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsAug 30Sale94.158,557805,642127,631Aug 31 11:43 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsAug 29Option Exercise38.711,44355,851129,074Aug 31 11:43 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsAug 29Sale94.161,443135,866127,631Aug 31 11:43 AM
STEWART MARTA REVP-Finance and CFOAug 25Option Exercise62.751,59399,95310,797Aug 29 10:36 AM
Hurlbut Thomas EVice President and ControllerAug 24Sale92.2885078,43810,730Aug 25 02:30 PM
STEWART MARTA REVP-Finance and CFOAug 19Sale91.541,562142,9859,204Aug 19 03:48 PM
STEWART MARTA REVP-Finance and CFOAug 18Sale91.581,502137,55310,766Aug 19 03:48 PM
Hurlbut Thomas EVice President and ControllerAug 17Option Exercise38.711,01739,36312,597Aug 18 04:52 PM
Hurlbut Thomas EVice President and ControllerAug 17Sale89.301,01790,81811,580Aug 18 04:52 PM
Hurlbut Thomas EVice President and ControllerAug 03Sale88.3552846,64711,580Aug 04 11:59 AM
Hurlbut Thomas EVice President and ControllerMay 05Sale89.9266860,07012,203May 06 02:24 PM
Earhart Cynthia CExec. VP - Admin. and CIOApr 25Option Exercise49.566,500322,1086,500Apr 26 04:51 PM
Earhart Cynthia CExec. VP - Admin. and CIOApr 25Sale90.046,500585,2480Apr 26 04:51 PM
AET Aetna Inc. daily Stock Chart
AET [NYSE]
Aetna Inc.
IndexS&P 500 P/E20.46 EPS (ttm)6.41 Insider Own0.20% Shs Outstand325.01M Perf Week1.98%
Market Cap42.63B Forward P/E13.38 EPS next Y9.80 Insider Trans-13.37% Shs Float310.50M Perf Month2.62%
Income2.27B PEG1.54 EPS next Q2.37 Inst Own97.90% Short Float2.90% Perf Quarter7.48%
Sales63.16B P/S0.68 EPS this Y-5.50% Inst Trans0.10% Short Ratio3.10 Perf Half Y18.82%
Book/sh50.81 P/B2.58 EPS next Y10.44% ROA3.40% Target Price138.76 Perf Year17.19%
Cash/sh55.37 P/C2.37 EPS next 5Y13.28% ROE12.90% 52W Range103.97 - 135.70 Perf YTD6.41%
Dividend2.00 P/FCF13.76 EPS past 5Y4.20% ROI7.40% 52W High-3.33% Beta0.55
Dividend %1.52% Quick Ratio- Sales past 5Y13.30% Gross Margin- 52W Low26.17% ATR1.96
Employees49500 Current Ratio- Sales Q/Q4.50% Oper. Margin7.30% RSI (14)59.79 Volatility1.79% 1.53%
OptionableYes Debt/Eq1.16 EPS Q/Q-56.90% Profit Margin3.60% Rel Volume1.79 Prev Close131.93
ShortableYes LT Debt/Eq1.06 EarningsMay 02 BMO Payout15.50% Avg Volume2.91M Price131.18
Recom2.40 SMA202.55% SMA502.30% SMA2008.74% Volume5,194,583 Change-0.57%
Apr-05-17Initiated Deutsche Bank Hold $135
Jan-24-17Downgrade Leerink Partners Outperform → Mkt Perform
Jan-04-17Initiated Piper Jaffray Neutral
Nov-14-16Downgrade Bernstein Outperform → Mkt Perform
Nov-11-16Upgrade Credit Suisse Neutral → Outperform
Jun-16-16Initiated Bernstein Outperform
Apr-29-16Reiterated RBC Capital Mkts Outperform $140 → $144
Feb-02-16Reiterated Wedbush Neutral $130 → $120
Feb-02-16Reiterated RBC Capital Mkts Outperform $142 → $140
Jan-08-16Downgrade Jefferies Buy → Hold
Dec-16-15Initiated Credit Suisse Neutral
Sep-18-15Upgrade Cantor Fitzgerald Hold → Buy
Sep-16-15Initiated JP Morgan Overweight
Sep-08-15Upgrade RBC Capital Mkts Sector Perform → Outperform $159 → $162
Jul-30-15Upgrade BofA/Merrill Neutral → Buy $132
Jul-06-15Downgrade FBR Capital Outperform → Mkt Perform $130
Jun-26-15Reiterated Leerink Partners Outperform $145 → $150
Jun-24-15Initiated RBC Capital Mkts Sector Perform $159
Jun-17-15Reiterated Leerink Partners Outperform $135 → $145
May-12-15Reiterated Leerink Partners Outperform $130 → $135
Apr-21-17 12:20AM  Insurers Offer Early Sign of ACA Exchange Plans for 2018 The Wall Street Journal
Apr-20-17 08:19AM  Aetna, Inc. breached its 50 day moving average in a Bullish Manner : AET-US : April 20, 2017 Capital Cube
05:30AM  Insurers Offer Early Sign of ACA Exchange Plans for 2018 The Wall Street Journal
Apr-19-17 07:20AM  Aetna (AET) Up 6.9% Since Earnings Report: Can It Continue? Zacks
Apr-18-17 05:00PM  Aetna to Announce First-Quarter 2017 Results Business Wire
10:40AM  UnitedHealth 1Q profit soars as ACA business shrinks Associated Press
09:30AM  UnitedHealth's Optum Profits Overcome Obamacare Exit Forbes
Apr-17-17 11:09AM  Aetna, Inc. : AET-US: Dividend Analysis : April 13th, 2017 (record date) : By the numbers : April 17, 2017 Capital Cube
Apr-13-17 05:57PM  Trump's 'Obamacare' fixes don't impress insurers Associated Press
04:58PM  Aetna (AET) Hurt by Exchange Business, High Medical Costs Zacks
Apr-07-17 08:04AM  3 Top Medicare Companies to Buy in 2017 Motley Fool
Apr-06-17 04:43PM  Aetna to stop selling individual health plans in Iowa Associated Press
04:39PM  [$$] Aetna to Exit Iowa's ACA Marketplace The Wall Street Journal
03:07PM  Iowa Obamacare market gets second big hit as insurer Aetna says it will drop out in 2018 CNBC
03:00PM  One of the nation's biggest health insurers is ditching Iowa's Obamacare exchanges Business Insider
01:43PM  Aetna exits Iowa individual insurance market for 2018 Reuters
01:41PM  Aetna to Exit Iowa Individual Insurance Market in 2018 TheStreet.com
01:22PM  Aetna exits Iowa individual insurance market for 2018 Reuters
12:01PM  Health Carriers Hanging Tough Despite D.C. Debacle Investopedia
11:34AM  Aetna exit from Iowa's 2018 Obamacare exchanges leaves just one insurer MarketWatch
11:27AM  Aetna To Leave Iowa's Obamacare Exchange Amid GOP Gridlock Forbes
09:30AM  The Zacks Analyst Blog Highlights: Aetna, BHP Billiton, Sprint, Capital One Financial and BlackBerry Zacks
Apr-04-17 05:42PM  3 Top Medicaid Stocks to Buy in 2017 Motley Fool
Apr-03-17 06:03PM  U.S. raises Medicare payments to insurers by 0.45 pct in 2018 Reuters
05:01PM  U.S. to raise Medicare payments to insurers 0.45 percent in 2018 Reuters
11:30AM  US stocks turn lower on Wall Street as automakers sink
Apr-02-17 11:31AM  5 Trade Ideas for Monday: Aetna, Great Plains Energy, Hartford Financial, Louisiana-Pacific and Newfield Exploration
09:43AM  CEO explains why political battles are a 'distraction' for the health-care business CNBC
Apr-01-17 04:23PM  ACA Repeal and Replace: Lots of Plans but No Plan B
Mar-31-17 01:18PM  About that GOP health reform, it was no big deal for health-care stocks in the first quarter at CNBC
Mar-30-17 08:26AM  Aetna, Inc. breached its 50 day moving average in a Bearish Manner : AET-US : March 30, 2017 Capital Cube
Mar-29-17 04:44PM  3 Top Health Insurance Stocks to Buy in 2017 Motley Fool
04:21PM  Why you can't ignore healthy people in the health insurance debate Yahoo Finance
Mar-28-17 06:56PM  Renewed Obamacare Repeal Effort Sends Hospital Stocks Down Investopedia
01:08PM  Negative Sentiment Will Impact Health Insurance Companies
Mar-27-17 04:43PM  Dr. Pearl: If delivery system not fixed, health care will... CNBC Videos
11:53AM  Why Exact Sciences is Soaring at Barrons.com
Mar-26-17 12:38PM  Obamacare Is Here To Stay For A Long Time, And That's Good News For Big Insurers at Forbes
09:19AM  More States To Expand Medicaid Now That Obamacare Remains Law at Forbes
Mar-24-17 08:49PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm GlobeNewswire
06:57PM  Here's how stocks could react now that the GOP health-care bill has been killed at CNBC
05:58PM  Some parts of Obamacare working well, problems with others
02:33PM  Former Aetna CEO Says Health Care Reform Still Far Away
01:15PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Aetna Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 27, 2017 - AET PR Newswire
11:22AM  INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:30AM  March 27 Deadline Alert: Law Offices of Howard G. Smith Reminds Aetna Inc. Investors of Upcoming Lead Plaintiff Deadline and Encourages Investors to Contact the Firm Business Wire
10:10AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aetna Inc. (AET) & Lead Plaintiff Deadline - March 27, 2017 GlobeNewswire
06:00AM  Healthcare scramble writes new chapter in Trump's 'Art of the Deal' Reuters
Mar-23-17 12:52PM  INVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
12:44PM  Healthcare Stocks Await TrumpCare Vote at Barrons.com
Mar-22-17 06:11PM  Molina Hit by Public Exchanges, Failed Aetna-Humana Merger
04:30PM  Hospital, Medicaid insurer shares set for volatility as health vote nears Reuters
11:00AM  How Mobile Apps Reduce Follow-Up Visits After Surgery at Forbes
07:15AM  Health care stocks under GOP plan
Mar-21-17 04:28PM  AETNA INC /PA/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligat
03:53PM  Health Insurance Lobby Backs Trumpcare Revisions at Forbes
10:14AM  AET INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Aetna Inc. and a Lead Plaintiff Deadline of March 27, 2017 GlobeNewswire
09:35AM  Should Value Investors Consider Aetna (AET) Stock?
Mar-20-17 09:56PM  [$$] White House Set to Announce Head of Senate Legislative Affairs Team at The Wall Street Journal
11:01AM  SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
Mar-19-17 09:31AM  U.S. Republicans working on Medicaid, tax credit changes-Ryan Reuters
Mar-18-17 02:22PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Aetna Inc. to Contact the Firm Before Imminent Lead Plaintiff Deadline Accesswire
01:00PM  Obamacare Repeal to Cut Deficit, but Greatly Expand Ranks of Uninsured
Mar-17-17 05:43PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Aetna Inc. -- AET PR Newswire
03:02PM  Justice Department Probing Health Insurers Over Medicare Fraud Allegations
01:06PM  U.S. probing insurers beyond UnitedHealth over Medicare charges Reuters
11:45AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of Aetna Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 27, 2017 AET GlobeNewswire
11:25AM  SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
Mar-16-17 12:13PM  Obamacare Repeal Takes Another Step but GOP Showdown Looms
10:30AM  Investor Alert: GPM Reminds Investors of the March 27 Deadline in the Class Action Lawsuit Against Aetna Inc. Business Wire
Mar-15-17 04:56PM  Rep. Garrett: Good things in GOP health bill, but there a...
Mar-14-17 04:16PM  AETNA INC /PA/ Files SEC form 8-K, Regulation FD Disclosure
02:57PM  Humana selling bonds to raise $1 billion at bizjournals.com
01:49PM  Republicans on defense after report shows millions would lose insurance Reuters
11:45AM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aetna Inc. (AET) and Lead Plaintiff Deadline - March 27, 2017 Accesswire
Mar-13-17 02:29PM  Aetna: A Bullish Setup for Aggressive Traders
12:12PM  Humana Inc. -- Moody's rates Humana's senior notes Baa3; outlook stable at Moody's
10:37AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Aetna Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 27, 2017 Business Wire
10:28AM  Aetna, Inc. :AET-US: Earnings Analysis: Q4, 2016 By the Numbers : March 13, 2017
Mar-12-17 08:02PM  Health law's woes, real or perceived, drive call for repeal
Mar-10-17 04:21PM  Brookings: 15M could lose health care coverage with new p...
01:32PM  Aetna, Inc. :AET-US: Earnings Analysis: 2016 By the Numbers : March 10, 2017
10:18AM  House leader: 'very difficult' to speed up end to Medicaid expansion Reuters
Mar-09-17 12:19PM  Trumpcare Won't Make Health Insurers Sick at The Wall Street Journal
Mar-08-17 01:40PM  Democrats fight Trump-backed U.S. healthcare plan, Ryan defends it Reuters
11:59AM  INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:34AM  AET SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Aetna Inc. and a Lead Plaintiff Deadline of March 27, 2017 Business Wire
09:40AM  House panels to launch fight in Congress over Obamacare replacement Reuters
Mar-07-17 05:50PM  Conservatives rebel against Trump-backed Republican healthcare plan Reuters
01:09PM  Today's charts: Aetna, Humana, Cigna and Anthem on the move after new GOP health care bill
11:14AM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:22AM  Healthcare stocks slide after the GOP releases its plan to repeal Obamacare
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aetna Inc. (AET) and Lead Plaintiff Deadline: March 27, 2017 Accesswire
07:54AM  Early movers: DKS, MIK, NAV, PFE, AET, CSX, & more at CNBC
06:31AM  What's working: Health care stocks after Obamacare
Mar-06-17 03:32PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
Mar-05-17 09:02AM  Rift Widens, Fractures Grow Among Republicans On Obamacare at Forbes
Mar-03-17 02:06PM  Aetna, Inc. : AET-US: Dividend Analysis : January 12th, 2017 (record date) : By the numbers : March 3, 2017
Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis. It also provides point-of-service, preferred provider organization, health maintenance organization, and indemnity benefit plans, as well as health savings accounts and consumer-directed health plans. In addition, this segment offers Medicare and Medicaid products and services, as well as other medical products, such as medical management and data analytics services, medical stop loss insurance, workers' compensation administrative services, and products that provide access to its provider networks in select geographies. The Group Insurance segment offers life insurance products, including group term life insurance, voluntary spouse and dependent term life insurance, group universal life insurance, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which provide the benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. The Large Case Pensions segment manages various retirement products, including pension and annuity products primarily for tax-qualified pension plans. The company provides its products and services to employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. was founded in 1853 and is based in Hartford, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GUERTIN SHAWN MExec. Vice President, CFOMar 23Sale128.418,4341,083,00944,880Mar 23 04:25 PM
GUERTIN SHAWN MExec. Vice President, CFOMar 22Option Exercise101.5379,1198,033,139123,999Mar 23 04:25 PM
GUERTIN SHAWN MExec. Vice President, CFOMar 22Sale128.619,4971,221,37944,880Mar 23 04:25 PM
GUERTIN SHAWN MExec. Vice President, CFOMar 21Option Exercise72.2642,2503,052,98587,130Mar 23 04:25 PM
GUERTIN SHAWN MExec. Vice President, CFOMar 21Sale130.6211,6711,524,51444,880Mar 23 04:25 PM
SOISTMAN FRANCIS S JRExec. VP, Government ServicesMar 08Sale131.986,607872,02023,454Mar 10 04:09 PM
SOISTMAN FRANCIS S JRExec. VP, Government ServicesMar 06Option Exercise72.6054,8333,980,87671,680Mar 07 05:47 PM
McCarthy Margaret MEVP, Operations & TechnologyFeb 22Sale128.877,9301,021,91148,310Feb 24 04:31 PM
Bertolini Mark TChairman and CEOFeb 03Option Exercise42.57148,1386,306,235391,808Feb 07 04:27 PM
Coye Molly JoelDirectorNov 30Sale131.171,145150,1877,517Dec 02 05:11 PM
Lynch Karen SPresidentNov 11Sale119.5545,0005,379,92651,254Nov 15 04:06 PM
Coye Molly JoelDirectorNov 09Sale116.96862100,8208,662Nov 14 05:33 PM
SOISTMAN FRANCIS S JRExec. VP, Government ServicesNov 07Sale109.789,1501,004,47812,367Nov 09 04:14 PM
GARTEN JEFFREY EDirectorSep 07Sale116.517,100827,2149,398Sep 09 04:12 PM
GUERTIN SHAWN MExec. Vice President, CFOAug 23Sale120.318,140979,32344,883Aug 24 04:32 PM
GUERTIN SHAWN MExec. Vice President, CFOAug 22Option Exercise72.2640,0002,890,40084,883Aug 24 04:32 PM
GUERTIN SHAWN MExec. Vice President, CFOAug 22Sale120.1937,1884,469,74844,883Aug 24 04:32 PM
McCarthy Margaret MEVP, Operations & TechnologyMay 10Sale114.4539,1694,483,01056,240May 12 06:06 PM
Bertolini Mark TChairman and CEOMay 03Sale114.0033,5103,820,157390,018May 04 04:20 PM
Bertolini Mark TChairman and CEOMay 02Option Exercise39.93106,5704,255,340496,588May 04 04:20 PM
SRE Sempra Energy daily Stock Chart
SRE [NYSE]
Sempra Energy
IndexS&P 500 P/E20.59 EPS (ttm)5.47 Insider Own0.10% Shs Outstand250.65M Perf Week0.91%
Market Cap28.20B Forward P/E19.95 EPS next Y5.64 Insider Trans-27.51% Shs Float250.27M Perf Month0.52%
Income1.37B PEG2.09 EPS next Q1.65 Inst Own83.60% Short Float1.84% Perf Quarter10.66%
Sales10.20B P/S2.76 EPS this Y1.50% Inst Trans0.04% Short Ratio4.73 Perf Half Y9.14%
Book/sh51.67 P/B2.18 EPS next Y10.54% ROA3.10% Target Price117.36 Perf Year15.24%
Cash/sh1.39 P/C80.81 EPS next 5Y9.87% ROE11.20% 52W Range91.57 - 113.15 Perf YTD12.64%
Dividend3.29 P/FCF- EPS past 5Y-0.20% ROI3.90% 52W High-0.56% Beta0.52
Dividend %2.92% Quick Ratio0.50 Sales past 5Y0.30% Gross Margin96.80% 52W Low22.88% ATR1.48
Employees16575 Current Ratio0.50 Sales Q/Q8.20% Oper. Margin15.30% RSI (14)61.68 Volatility1.31% 1.27%
OptionableYes Debt/Eq1.32 EPS Q/Q3.10% Profit Margin13.40% Rel Volume1.51 Prev Close112.29
ShortableYes LT Debt/Eq1.11 EarningsMay 30 BMO Payout54.20% Avg Volume975.78K Price112.52
Recom2.00 SMA201.30% SMA503.29% SMA2007.68% Volume1,471,949 Change0.20%
Feb-29-16Reiterated Barclays Overweight $111 → $110
Jan-25-16Reiterated RBC Capital Mkts Outperform $119 → $116
May-06-15Reiterated Barclays Overweight $117 → $120
Sep-22-14Reiterated RBC Capital Mkts Outperform $106 → $115
Aug-14-14Reiterated UBS Buy $106 → $111
Apr-14-14Initiated UBS Buy $106
Apr-02-14Reiterated RBC Capital Mkts Outperform $102 → $104
Jan-06-14Reiterated Barclays Overweight $101 → $97
May-28-13Upgrade Barclays Equal Weight → Overweight $85 → $90
Apr-24-13Reiterated Barclays Equal Weight $77 → $85
Apr-23-13Downgrade ISI Group Buy → Neutral
Feb-27-13Reiterated Barclays Equal Weight $70 → $77
Jan-07-13Upgrade ISI Group Neutral → Buy
Jul-23-12Downgrade Argus Buy → Hold
Apr-03-12Reiterated Barclays Equal Weight $60 → $63
Nov-07-11Reiterated RBC Capital Mkts Sector Perform $54 → $57
Jun-24-11Initiated RBC Capital Mkts Sector Perform $55
Apr-08-11Reiterated Barclays Capital Equal Weight $54 → $57
Feb-28-11Downgrade Barclays Capital Overweight → Equal Weight $57 → $55
Dec-10-10Initiated Oppenheimer Perform $56
Apr-12-17 04:30PM  Sempra Energy's IEnova Unit To Report First-Quarter 2017 Earnings April 25 PR Newswire
Apr-10-17 11:41AM  Sempra Energy : SRE-US: Dividend Analysis : March 23rd, 2017 (record date) : By the numbers : April 10, 2017 Capital Cube
Apr-07-17 12:10PM  Split results for stocks on Syria strike and weak jobs gains Associated Press
Apr-06-17 08:27AM  Sempra Energy Offers Long-Term Outlook, Keeps FY17 View Zacks
Apr-05-17 11:40AM  Sempra Energy Updates Financial Outlook At 2017 Analyst Conference PR Newswire
Apr-03-17 05:21PM  SDG&E Reports Highest Level Of Diverse Business Enterprise Spending In Company History PR Newswire
Mar-30-17 02:33PM  SoCalGas and University of California Irvine Demonstrate Power-to-Gas Technology Can Dramatically Increase the Use of Renewable Energy PR Newswire
Mar-29-17 02:19PM  In Lead-up to SoCalGas Pipeline Completion, CR&R Environmental Begins Using Carbon-Neutral Renewable Natural Gas PR Newswire
Mar-24-17 02:00PM  SoCalGas Announces Launch of Interactive Online Tool for Sharing Aliso Canyon Infrared Methane Monitoring Data PR Newswire
Mar-22-17 09:00AM  Sempra Energy To Webcast Analyst Conference April 5 PR Newswire
Mar-20-17 11:22AM  Sempra Energy Stock Trades Ex-Dividend Tuesday Investopedia
Mar-16-17 04:42PM  SDG&E Spurs Energy Storage Innovation With Flow Battery Technology PR Newswire
Mar-15-17 07:37AM  Sempra Energys Dividend Profile, Inside Out Market Realist
Mar-14-17 06:05PM  These Big Utilities Are Paying Higher Dividends Now
04:14PM  Sempras Long-Term Dividend Growth: What Its Position?
04:14PM  Sempra Energys Dividend: Why the Low Yield?
04:14PM  SEMPRA ENERGY Files SEC form 8-K, Change in Directors or Principal Officers
10:12AM  SoCalGas Joins Gold Shovel Standard to Improve Excavation Safety and Reduce Pipeline Damage PR Newswire
08:15AM  Post Earnings Coverage as Public Service Enterprise's Adjusted EPS Grew 8% Accesswire
07:00AM  Sempra Energy Appoints Contreras-Sweet To Board Of Directors PR Newswire
Mar-07-17 11:00AM  P. Kevin Chase Appointed Chief Information Officer For Sempra Energy PR Newswire
Mar-06-17 12:17AM  [$$] How California Utilities Are Managing Excess Solar Power at The Wall Street Journal
Mar-04-17 01:04PM  SEMPRA ENERGY Financials
07:30AM  [$$] How California Utilities Are Managing Excess Solar Power at The Wall Street Journal
07:00AM  How California Utilities Are Managing Excess Solar Power
Mar-02-17 09:18AM  Sempra Energy :SRE-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017
Mar-01-17 11:17AM  Sempra Energy :SRE-US: Earnings Analysis: 2016 By the Numbers : March 1, 2017
09:28AM  Maxwell (MXWL) Q4 Loss Wider than Expected, Revenues Beat
09:26AM  Sempra Energy Puts Some Major Issues to Bed in the Fourth Quarter at Motley Fool
01:00AM  U.S. military marches forward on green energy, despite Trump Reuters
Feb-28-17 11:18PM  Edited Transcript of SRE earnings conference call or presentation 28-Feb-17 5:00pm GMT
04:43PM  Sempra Energy Appoints Two New Directors PR Newswire
12:23PM  Sempra Energy (SRE) Beats on Q4 Earnings, Lifts '17 View
11:38AM  SEMPRA ENERGY Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
10:11AM  [$$] Sempra Energy Increases Earnings Guidance at The Wall Street Journal
09:46AM  Sempra Energy (SRE) Tops Q4 Earnings, Misses on Revenues
08:51AM  Sempra beats 4Q profit forecasts
08:30AM  Sempra Energy Announces 2016 Earnings PR Newswire
07:07AM  Q4 2016 Sempra Energy Earnings Release - 08:30 am ET
Feb-27-17 04:20PM  SEMPRA ENERGY Files SEC form 8-K, Change in Directors or Principal Officers
11:49AM  14 Dividend Stocks Rewarding Shareholders With A Raise at Insider Monkey
Feb-24-17 09:00AM  SDG&E Unveils World's Largest Lithium Ion Battery Energy Storage Facility PR Newswire
06:58AM  Will Sempra Energy (SRE) Upset Investors in Q4 Earnings?
Feb-23-17 01:41PM  Sempra Energy Raises Annualized Dividend By 9 Percent PR Newswire
Feb-16-17 02:30PM  SoCalGas to Install up to 60 New Valves in 2017 to Enhance Pipeline System Safety PR Newswire
Feb-15-17 03:15PM  Sempra Energy : SRE-US: Dividend Analysis : December 29th, 2016 (record date) : By the numbers : February 15, 2017
Feb-14-17 09:00AM  Sempra Energy To Report Fourth-Quarter 2016 Earnings Feb. 28 PR Newswire
Feb-13-17 04:41PM  SoCalGas to Feature Biogas Technology and Powerful New Compressed Natural Gas Big Rigs at 50th Annual World Agricultural Expo PR Newswire
Feb-10-17 01:06PM  SoCalGas Declares Preferred Dividends PR Newswire
Feb-09-17 03:02PM  SoCalGas Pilot Biogas Project Selected by U.S. Energy Department for Funding PR Newswire
Feb-08-17 06:05PM  What Analysts Think about PG&E ahead of 4Q16 Earnings
Feb-07-17 04:48PM  Sempra Energy Announces California Utilities' Settlement Agreement For Two-Year Extension Of Cost-Of-Capital Application PR Newswire
04:45PM  SEMPRA ENERGY Files SEC form 8-K, Other Events
Feb-06-17 12:46PM  TransCanada Corporation's 3 Biggest Growth Opportunities at Motley Fool
Feb-02-17 12:05PM  Utility Stocks: Analyzing Returns and Implied Volatilities
10:18AM  Why Is NRG Energys Implied Volatility Up?
Feb-01-17 08:05AM  Sempra Energy breached its 50 day moving average in a Bullish Manner : SRE-US : February 1, 2017
Jan-31-17 03:46PM  SoCalGas and CR&R Environmental Announce Construction of Pipeline to Provide Carbon-Neutral Renewable Natural Gas PR Newswire
Jan-30-17 04:21PM  Sempra to Use Moon-Mission Technology to Back Up Substations at Bloomberg
03:05PM  SoCalGas Offers Tips on Reducing Winter Gas Bills PR Newswire
Jan-26-17 05:50PM  SoCalGas Advisory Lifted PR Newswire
Jan-25-17 01:44PM  SoCalGas says stops natgas withdrawal from Aliso Canyon storage facility
Jan-24-17 05:01PM  SoCalGas says ceases natgas withdrawal from Aliso Canyon storage facility
Jan-23-17 05:15PM  California utilities seek $1 bln for vehicle electrification Reuters
09:45AM  SoCalGas Advisory Now in Effect PR Newswire
Jan-22-17 04:41PM  SoCalGas Announces "SoCalGas Advisory" PR Newswire
Jan-20-17 08:43PM  SDG&E Aims To Reduce Air Pollution By Deploying Electric Vehicle Charging Throughout The Community PR Newswire
Jan-17-17 09:28PM  SoCalGas Statement on California Department of Conservation's Division of Oil, Gas and Geothermal Resources Announcement of Public Meeting PR Newswire
06:46PM  California moves toward reopening Aliso Canyon gas storage field Reuters
04:18PM  California to hold public meeting on Aliso Canyon natgas facility Reuters
Jan-16-17 10:03AM  Mexico's IEnova will invest $800 mln in 2017 on 8 projects - CEO
Jan-11-17 02:42PM  SoCalGas Announces Funding for Demonstration of Mobile CNG Refueling Solution Developed by Onboard Dynamics, Inc. PR Newswire
Jan-10-17 06:03PM  SoCalGas to Use Fiber Optic Technology to Monitor Pipelines in Real Time PR Newswire
10:10AM  Houston area dominates list of best energy cos. to work for in the U.S. at bizjournals.com
Jan-03-17 04:36PM  SDG&E President, Scott D. Drury, Begins Role PR Newswire
Dec-30-16 07:37AM  SRE, EIX, and PCG: Analyzing Utilities Current Valuations
Dec-29-16 09:08AM  Whats Next for Sempra Energy Stock?
07:37AM  Analysts Expect a Handsome Upside for Sempra Energy in 2017
Dec-28-16 07:50AM  Sempra Energy breached its 50 day moving average in a Bearish Manner : SRE-US : December 28, 2016
Dec-20-16 03:29PM  SoCalGas Lifts "SoCalGas Advisory" PR Newswire
Dec-19-16 02:14PM  SDG&E Urges Customers To Be On "High Alert" For Scam Artists PR Newswire
08:29AM  Sempra Energy (SRE) Unit Buys Ventika Facility in Mexico
Dec-18-16 08:59PM  SoCalGas Issues "SoCalGas Advisory" PR Newswire
Dec-16-16 01:07PM  Sempra Energy Declares Common Dividend PR Newswire
Dec-15-16 06:24PM  Sempra Energy Unit IEnova Completes Acquisition Of Ventika Wind Generation Facilities In Mexico PR Newswire
04:43PM  SDG&E To Upgrade Infrastructure In Orange County To Improve Reliability And Public Safety PR Newswire
12:33PM  SoCalGas Completes More than 700,000 Safety Checks in First Year of Meter Inspection Program PR Newswire
Dec-14-16 06:38PM  SDG&E Transforming Vehicle Fleet PR Newswire
02:23PM  MIT Wins Peeptrade's Global Investment Challenge
11:13AM  Sempra Energy Value Analysis (NYSE:SRE) : December 14, 2016
Dec-13-16 07:26AM  Sempra Energy breached its 50 day moving average in a Bullish Manner : SRE-US : December 13, 2016
Dec-08-16 08:46AM  Hedge Funds Are Selling Sempra Energy (SRE) at Insider Monkey
Dec-06-16 03:17PM  Clean Energy Milestone: 100,000th Private Solar Array Connected To SDG&E's Power Grid PR Newswire
Sempra Energy, together with its subsidiaries, engages in energy business worldwide. The company's San Diego Gas & Electric Company segment transmits and distributes electricity and/or natural gas. As of December 31, 2016, this segment had approximately 1.4 million electric meters and 878,000 natural gas meters. Its Southern California Gas Company segment purchases, transports, sells, distributes, and stores natural gas. As of December 31, 2015, this segment had approximately 5.9 million customer meters. The company's Sempra South American Utilities segment provides electricity distribution services through 10,118 miles of distribution lines, 352 miles of transmission lines, and 48 substations located in the region of Valparaiso in central Chile, as well as through 13,763 miles of distribution lines, 194 miles of transmission lines, and 39 substations located in the Cusco region of Peru. Its Sempra Mexico segment owns, develops, and operates natural gas pipelines, ethane systems, and a liquid petroleum gas pipeline and associated storage terminals; electric generation facilities; natural gas distribution systems; and liquefied natural gas (LNG) regasification terminals. The company's Sempra Renewables segment is involved in the investment and development of wind and solar power generation facilities. Its Sempra LNG & Midstream segment invests in and develops LNG-related infrastructure in North America; develops and operates natural gas storage facilities in Alabama and Mississippi; and owns a liquefaction project in Louisiana. The company primarily serves residential, commercial, and industrial customers. Sempra Energy was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OUCHI WILLIAM GDirectorMar 06Option Exercise46.025,000230,10021,247Mar 06 03:34 PM
OUCHI WILLIAM GDirectorMar 06Sale108.925,000544,60016,247Mar 06 03:34 PM
RUTLEDGE WILLIAM PDirectorMar 02Option Exercise52.5910,000525,85015,846Mar 02 05:45 PM
OUCHI WILLIAM GDirectorMar 02Sale109.8760065,92216,247Mar 03 02:42 PM
RUTLEDGE WILLIAM PDirectorMar 02Sale109.6915,2621,674,089584Mar 02 05:45 PM
DAVIS STEVEN DCorp. Group PresidentFeb 13Sale105.002,233234,46520,567Feb 13 05:18 PM
HOUSEHOLDER JOSEPH ACorp. Group PresidentJan 24Sale102.106,472660,79147,425Jan 24 08:43 PM
REED DEBRA LChairman and CEOJan 23Sale102.3417,3001,770,482127,645Jan 23 07:20 PM
ROWLAND G JOYCESenior VPJan 19Sale102.592,862293,6131Jan 19 02:00 PM
Martin Jeffrey WExecutive VP and CFOJan 10Sale100.954,266430,6730Jan 10 01:57 PM
HOUSEHOLDER JOSEPH AExecutive VP and CFODec 12Option Exercise61.4112,000736,92059,425Dec 13 04:42 PM
SNELL MARK APresidentDec 12Sale103.0635,0003,607,10037,914Dec 13 04:41 PM
HOUSEHOLDER JOSEPH AExecutive VP and CFODec 12Sale102.6912,0001,232,28047,425Dec 13 04:42 PM
ROWLAND G JOYCESenior VPDec 08Sale99.1212512,3901Dec 09 04:11 PM
BOECKMANN ALAN LDirectorNov 29Buy101.526,000609,1166,000Nov 29 06:26 PM
MIHALIK TREVOR ISVP, Controller and CAOAug 10Sale106.865,659604,7212,615Aug 10 05:02 PM
RUTLEDGE WILLIAM PDirectorAug 08Option Exercise64.815,000324,05010,838Aug 08 07:52 PM
RUTLEDGE WILLIAM PDirectorAug 08Sale107.205,000536,0005,838Aug 08 07:52 PM
SNELL MARK APresidentMay 06Sale103.9950,0005,199,50072,909May 09 03:44 PM
BDX Becton, Dickinson and Company daily Stock Chart
BDX [NYSE]
Becton, Dickinson and Company
IndexS&P 500 P/E30.79 EPS (ttm)6.02 Insider Own0.30% Shs Outstand213.06M Perf Week1.48%
Market Cap39.48B Forward P/E17.80 EPS next Y10.41 Insider Trans-7.89% Shs Float212.20M Perf Month1.45%
Income1.31B PEG3.02 EPS next Q2.24 Inst Own85.50% Short Float1.33% Perf Quarter7.97%
Sales12.42B P/S3.18 EPS this Y34.00% Inst Trans0.21% Short Ratio3.38 Perf Half Y8.50%
Book/sh35.59 P/B5.21 EPS next Y10.19% ROA5.10% Target Price189.14 Perf Year18.62%
Cash/sh4.40 P/C42.13 EPS next 5Y10.21% ROE16.90% 52W Range155.09 - 186.40 Perf YTD12.37%
Dividend2.92 P/FCF34.48 EPS past 5Y-3.30% ROI6.90% 52W High-0.60% Beta1.05
Dividend %1.58% Quick Ratio0.80 Sales past 5Y10.50% Gross Margin48.60% 52W Low19.47% ATR2.06
Employees50900 Current Ratio1.10 Sales Q/Q-2.10% Oper. Margin15.20% RSI (14)58.77 Volatility0.99% 1.01%
OptionableYes Debt/Eq1.45 EPS Q/Q143.80% Profit Margin10.50% Rel Volume0.69 Prev Close186.05
ShortableYes LT Debt/Eq1.19 EarningsMay 04 BMO Payout44.10% Avg Volume832.74K Price185.29
Recom2.30 SMA200.82% SMA501.45% SMA2006.38% Volume577,681 Change-0.41%
Jan-05-17Downgrade Raymond James Strong Buy → Outperform
Jan-03-17Downgrade JP Morgan Overweight → Neutral
Sep-23-16Downgrade Citigroup Neutral → Sell
May-09-16Reiterated RBC Capital Mkts Sector Perform $153 → $169
Feb-11-16Upgrade Deutsche Bank Hold → Buy $155 → $163
Feb-04-16Reiterated RBC Capital Mkts Sector Perform $162 → $153
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-12-15Initiated Citigroup Neutral
Aug-19-15Reiterated Argus Buy $156 → $167
Aug-10-15Reiterated Deutsche Bank Hold $147 → $155
Aug-07-15Reiterated RBC Capital Mkts Sector Perform $150 → $162
Jul-02-15Resumed Barclays Equal Weight $158
Jun-29-15Upgrade UBS Neutral → Buy $159 → $167
Mar-24-15Reiterated Canaccord Genuity Hold $125 → $149
Mar-10-15Initiated UBS Neutral $159
Feb-11-15Reiterated Argus Buy $140 → $156
Feb-06-15Reiterated RBC Capital Mkts Outperform $145 → $150
Oct-08-14Reiterated RBC Capital Mkts Sector Perform $116 → $132
Oct-07-14Upgrade Stifel Hold → Buy $153
Oct-07-14Reiterated Canaccord Genuity Hold $113 → $125
Apr-24-17 12:23AM  Dow, S&P 500 Futures Soar On French Election Results Investor's Business Daily
12:01AM  Becton Dickinson to Acquire C.R. Bard for $24 Billion The Wall Street Journal
Apr-23-17 10:23PM  Becton, Dickinson and Company -- Moody's places Becton's Baa2/P-2 ratings on review for downgrade Moody's
09:23PM  Act Now - Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of C.R. Bard, Inc. - BCR PR Newswire
08:57PM  Becton Dickinson to acquire Bard for $24 billion Reuters
07:47PM  Becton Dickinson to Buy C.R. Bard for $24 Billion The Wall Street Journal
07:22PM  BD to Buy Bard for $24 Billion TheStreet.com
06:07PM  BD to acquire Bard in $24 bln medical tech deal Reuters
05:05PM  BD Announces Appointment Of Tom Polen As President PR Newswire
05:04PM  BD To Acquire Bard For $24 Billion PR Newswire
Apr-19-17 02:52PM  Becton, Dickinson & Co. Value Analysis (NYSE:BDX) : April 19, 2017 Capital Cube
Apr-18-17 08:33AM  Becton, Dickinson & Co. breached its 50 day moving average in a Bullish Manner : BDX-US : April 18, 2017 Capital Cube
Apr-07-17 10:06AM  Becton (BDX) Gets FDA 510(k) for New Flow Cytometer System Zacks
Apr-06-17 07:00AM  These 4 Blue Chips Are Sending Buy Signals in April: AT&T, Becton and More TheStreet.com
06:59AM  BD Receives FDA 510(k) Clearance for New Flow Cytometer System with Leucocount Reagent Assay PR Newswire
Apr-05-17 10:16AM  Becton, Dickinson Takes Over Caesarea Medical Electronics Zacks
03:18AM  Becton, Dickinson and Company (BDX) Up 3.8% Since Earnings Report: Can It Continue? Zacks
Apr-04-17 04:30PM  BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call PR Newswire
11:01AM  Becton, Dickinson & Co. : BDX-US: Dividend Analysis : March 10th, 2017 (record date) : By the numbers : April 4, 2017 Capital Cube
11:00AM  BD Completes Acquisition Of Caesarea Medical Electronics PR Newswire
Apr-03-17 06:59AM  BD Launches "Power in Prevention" Program to Help Minimize Risk of Infections during Surgical Process at 2017 AORN Annual Conference PR Newswire
Mar-19-17 11:12AM  Dividend Aristocrats: Medtronic vs. Becton, Dickinson & Company GuruFocus.com
Mar-06-17 09:30AM  The Zacks Analyst Blog Highlights: JPMorgan, Caterpillar, Broadcom, Mondelez and Becton Dickinson Zacks
Mar-03-17 11:14AM  Is Becton, Dickinson a Cure for a Sick Portfolio? TheStreet.com
Mar-01-17 06:59AM  Pyxis ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care GlobeNewswire
Feb-22-17 08:00AM  BD To Present At Inaugural CECP CEO Investor Forum PR Newswire
06:59AM  BD Veritor System Meets FDA's New Performance Requirements for Rapid Influenza Antigen Detection Tests PR Newswire
Feb-21-17 06:59AM  BD Partnership Honored by U.S. Chamber of Commerce Foundation at the Health Means Business National Summit with Healthy10 Award PR Newswire
Feb-20-17 06:59AM  BD Demonstrates Synchronized Technology Platform at HIMSS17 PR Newswire
Feb-17-17 08:00AM  BD to Present at Investor Healthcare Conferences PR Newswire
Feb-16-17 08:15AM  Post Earnings Coverage as Becton, Dickinson and Co.'s Revenue Grew 6.1%; Adjusted EPS Gained 19.4% on Currency Neutral Basis Accesswire
06:59AM  BD Initiates New Industry Alliance To Combat Rising Opioid Crisis PR Newswire
Feb-14-17 09:32AM  Becton, Dickinson Launches BD Resolve Early Access Program
Feb-13-17 06:59AM  BD Announces Early Access Program for BD Resolve Single-Cell Analysis Platform PR Newswire
Feb-08-17 01:04PM  BECTON DICKINSON & CO Financials
Feb-06-17 01:42PM  ETFs with exposure to Becton, Dickinson & Co. : February 6, 2017
Feb-03-17 11:48AM  Becton, Dickinson & Co. :BDX-US: Earnings Analysis: Q1, 2017 By the Numbers : February 3, 2017
Feb-02-17 01:06PM  BECTON DICKINSON & CO Files SEC form 10-Q, Quarterly Report
11:53AM  Edited Transcript of BDX earnings conference call or presentation 2-Feb-17 1:00pm GMT
10:14AM  Becton, Dickinson (BDX) Beats on Q1 Earnings & Revenues
08:01AM  Early movers: MRK, FB, BDX, CI, M, DLPH, EL & more at CNBC
08:00AM  Becton Dickinson and Co Earnings Call scheduled for 8:00 am ET today
07:43AM  Becton, Dickinson (BDX) Beats Q1 Earnings & Revenues
07:18AM  [$$] Becton Dickinson's Earnings Jump, and It Raises 2017 Outlook at The Wall Street Journal
07:18AM  Market Recon: The Market Has Run as Far as It Could on Hope
07:07AM  Q1 2017 Becton Dickinson and Co Earnings Release - Before Market Open
06:30AM  Becton Dickinson beats Street 1Q forecasts
06:00AM  BD Announces Results For 2017 First Fiscal Quarter PR Newswire
Feb-01-17 08:44AM  Medical Product Earnings Due on Feb 2: BDX, BSX, IDXX, ATHN
Jan-30-17 01:16PM  Becton, Dickinson & Co. : BDX-US: Dividend Analysis : December 09th, 2016 (record date) : By the numbers : January 30, 2017
10:13AM  Becton, Dickinson (BDX) Q1 Earnings: What's in the Cards?
Jan-26-17 11:18AM  BECTON DICKINSON & CO Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
06:59AM  New BD Institute For Medication Management Excellence Aims To Improve Patient Safety And Outcomes Through Collaboration PR Newswire
Jan-23-17 04:30PM  BD Board Declares Dividend PR Newswire
06:59AM  PleurX Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions PR Newswire
Jan-19-17 10:30AM  BECTON DICKINSON & CO Files SEC form 8-K, Entry into a Material Definitive Agreement
Jan-18-17 04:30PM  BD Announces Webcast of Annual Meeting of Shareholders PR Newswire
08:22AM  Becton, Dickinson Commercially Launches Precise WTA Kits
Jan-17-17 06:59AM  BD Launches Reagents to Simplify Single Cell Research PR Newswire
Jan-13-17 09:07AM  Inside Johnson & Johnsons Latest Dividend Payment
Jan-11-17 10:27AM  Becton, Dickinson & Co. Value Analysis (NYSE:BDX) : January 11, 2017
08:15AM  Post Earnings Coverage as AngioDynamics Adjusted EPS Soared 36% Accesswire
08:00AM  BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call PR Newswire
Jan-10-17 07:25AM  Becton, Dickinson & Co. breached its 50 day moving average in a Bullish Manner : BDX-US : January 10, 2017
Jan-09-17 08:00AM  BD to Present at the 35th Annual J. P. Morgan Healthcare Conference PR Newswire
Jan-05-17 05:42PM  Top 7 Dividend Health Care Stocks
07:35AM  How Do Wall Street Analysts View Becton Dickinson?
07:04AM  Becton Dickinson downgraded by Raymond James
Jan-04-17 10:35AM  A Look at Becton Dickinsons Recent Stock Performance
09:05AM  Inside Becton Dickinsons Financial Guidance for 2017
08:01AM  10 Great All-Weather Stocks at Kiplinger
07:35AM  BDs Latest Dividend Payment and Capital Allocation Strategy
Jan-03-17 10:36AM  A Look at BDXs Recent Product Launches
09:06AM  Analyzing the BD Medical Segments Product Pipeline
07:36AM  BDs Medical Segment Performance and Growth Strategy
Jan-02-17 10:37AM  BD Lifesciencess Product Pipeline Could Boost Its Fiscal 2017 Growth
09:07AM  BD Lifesciencess Performance and Core Focus Areas
07:37AM  Becton Dickinsons Long-Term Growth Profile and Expectations
Dec-29-16 12:56PM  Unusual activity: BDX & JBLU
12:48PM  Farr: My top 10 stocks for 2017 at CNBC
Dec-23-16 11:45AM  The 10 Best Dividend Aristocrats for 2017 and Beyond
09:21AM  What Do Analysts Recommend for Baxter International?
Dec-20-16 07:35AM  Inside Edwards Lifesciences Financial Guidance for 2017
Dec-19-16 10:35AM  Understanding the Key Drivers of EWs Critical Care Business Growth
Dec-15-16 06:59AM  BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics PR Newswire
Dec-12-16 06:00AM  5 Investing Ideas From Top Dividend-Stock Fund Managers at Morningstar
Dec-09-16 04:41PM  BECTON DICKINSON & CO Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Bal
Dec-08-16 12:15PM  ETFs with exposure to Becton, Dickinson & Co. : December 8, 2016
Dec-06-16 01:00PM  These 3 Stocks Just Raised Their Dividends at Motley Fool
Dec-05-16 12:38PM  BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management PR Newswire
10:38AM  BECTON DICKINSON & CO Files SEC form 8-K, Other Events
Dec-02-16 02:49PM  BECTON DICKINSON & CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Dec-01-16 05:30PM  BD Announces Pricing of Tender Offers PR Newswire
05:05PM  BECTON DICKINSON & CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits
01:11PM  BD Announces Early Tender Results and Upsizing of Maximum Tender Offers PR Newswire
06:59AM  BD Announces Adoption of Windows 10 'Internet of Things' for the Pyxis ES System PR Newswire
06:00AM  BD to Offer Euro-denominated Senior Unsecured Notes PR Newswire
Nov-30-16 09:22PM  Is Becton Dickinson and Co (BDX) A Good Stock To Buy Right Now? at Insider Monkey
04:02PM  Becton Dickinson Lifts Dividend by 11%
Nov-29-16 08:00AM  Upgrading Our Growth Forecast for Becton, Dickinson
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. The BD Medical segment offers syringes, pen needles, and IV sets for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; and prefillable drug delivery systems. The BD Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and women's health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation, and plated media products; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHERMAN JEFFREY SSr. VP and General CounselFeb 15Option Exercise72.1244,3643,199,53266,458Feb 16 08:57 AM
SHERMAN JEFFREY SSr. VP and General CounselFeb 15Sale180.0231,4645,664,24622,094Feb 16 08:57 AM
Conroy AlexandreExecutive Vice PresidentFeb 14Sale177.868,5001,511,81023,676Feb 15 11:31 AM
Gallagher John EVP, Corp Finance and TreasurerDec 15Sale168.821,793302,6942,796Dec 16 01:50 PM
Sichak StephenExecutive Vice PresidentDec 05Sale164.442,632432,8067,953Dec 06 01:48 PM
Sichak StephenExecutive Vice PresidentNov 04Option Exercise76.1818,2461,389,98026,892Nov 07 08:52 AM
Sichak StephenExecutive Vice PresidentNov 04Sale176.1010,3521,822,9878,646Nov 07 08:52 AM
Tharby Linda MExecutive Vice PresidentSep 06Option Exercise75.0120,2911,521,95722,146Sep 07 09:17 AM
Tharby Linda MExecutive Vice PresidentSep 06Sale177.2711,7042,074,8259,188Sep 07 09:17 AM
COHEN GARY MExecutive Vice PresidentAug 11Option Exercise76.6451,8333,972,481125,870Aug 12 09:40 AM
COHEN GARY MExecutive Vice PresidentAug 11Sale176.8129,3675,192,37974,037Aug 12 09:40 AM
Gallagher John EVP, Corp Finance and TreasurerJun 13Option Exercise76.183,500266,6306,758Jun 14 10:03 AM
Gallagher John EVP, Corp Finance and TreasurerJun 13Sale169.871,931328,0193,258Jun 14 10:03 AM
Shabshab NabilExecutive Vice PresidentJun 07Option Exercise74.219,055671,97811,363Jun 08 09:35 AM
Shabshab NabilExecutive Vice PresidentJun 07Sale168.755,080857,2506,700Jun 08 09:35 AM
SHERMAN JEFFREY SSr. VP and General CounselMay 17Option Exercise76.2263,2004,817,38660,932May 18 09:37 AM
SHERMAN JEFFREY SSr. VP and General CounselMay 17Sale166.2734,3735,715,19923,734May 18 09:37 AM
FORLENZA VINCENT AChairman, CEO and PresidentMay 13Option Exercise68.6064,5444,427,900207,225May 16 11:39 AM
Sichak StephenExecutive Vice PresidentMay 13Option Exercise72.1222,9151,652,63031,561May 16 10:56 AM
Sichak StephenExecutive Vice PresidentMay 13Sale166.4812,9952,163,4088,646May 16 10:56 AM
FORLENZA VINCENT AChairman, CEO and PresidentMay 13Sale166.1737,9336,303,327172,681May 16 11:39 AM
ORR JAMES FDirectorMay 10Sale167.661,368229,35923,045May 11 09:13 AM
Conroy AlexandreExecutive Vice PresidentMay 09Option Exercise71.8019,8111,422,36835,738May 10 02:26 PM
Lim James CExecutive Vice PresidentMay 09Sale165.605,257870,55912,556May 10 10:48 AM
Conroy AlexandreExecutive Vice PresidentMay 09Sale165.5811,2381,860,78825,611May 10 02:26 PM
Polen Thomas E JrExecutive Vice PresidentMay 06Option Exercise74.3613,256985,65313,087May 09 04:52 PM
Polen Thomas E JrExecutive Vice PresidentMay 06Sale163.907,2421,186,9645,789May 09 04:52 PM
RIMEL REBECCA WDirectorMay 06Sale163.69684111,9646,835May 09 04:02 PM
Hurwitz Jerome VExecutive Vice PresidentMay 06Sale163.583,878634,3633,027May 09 03:54 PM
Strahlman Ellen RSenior Vice PresidentMay 06Sale163.523,019493,6677,218May 09 03:44 PM
HUM Humana Inc. daily Stock Chart
HUM [NYSE]
Humana Inc.
IndexS&P 500 P/E52.80 EPS (ttm)4.05 Insider Own0.20% Shs Outstand149.54M Perf Week0.88%
Market Cap31.95B Forward P/E17.83 EPS next Y11.99 Insider Trans-57.92% Shs Float143.85M Perf Month0.35%
Income614.00M PEG3.98 EPS next Q2.46 Inst Own98.10% Short Float4.78% Perf Quarter6.76%
Sales54.38B P/S0.59 EPS this Y-51.80% Inst Trans-0.01% Short Ratio4.34 Perf Half Y23.28%
Book/sh71.45 P/B2.99 EPS next Y9.53% ROA2.30% Target Price224.88 Perf Year24.01%
Cash/sh25.93 P/C8.24 EPS next 5Y13.27% ROE5.70% 52W Range149.25 - 220.06 Perf YTD5.08%
Dividend1.60 P/FCF25.93 EPS past 5Y-13.60% ROI5.40% 52W High-2.91% Beta0.88
Dividend %0.75% Quick Ratio- Sales past 5Y8.10% Gross Margin- 52W Low43.16% ATR3.07
Employees51600 Current Ratio- Sales Q/Q-3.60% Oper. Margin3.20% RSI (14)57.56 Volatility1.31% 1.50%
OptionableYes Debt/Eq0.40 EPS Q/Q-499.90% Profit Margin1.10% Rel Volume1.08 Prev Close214.24
ShortableYes LT Debt/Eq0.35 EarningsMay 03 BMO Payout28.20% Avg Volume1.58M Price213.67
Recom2.10 SMA201.72% SMA501.39% SMA20011.80% Volume1,710,744 Change-0.27%
Apr-21-17Downgrade Jefferies Buy → Hold
Apr-05-17Initiated Deutsche Bank Hold $216
Mar-30-17Resumed Oppenheimer Outperform
Jan-27-17Resumed BofA/Merrill Buy
Jan-24-17Downgrade Stifel Buy → Hold $214 → $210
Jan-04-17Initiated Piper Jaffray Overweight
Dec-07-16Downgrade Cantor Fitzgerald Buy → Hold
Nov-11-16Upgrade Credit Suisse Neutral → Outperform
Nov-10-16Upgrade JP Morgan Neutral → Overweight
Oct-13-16Reiterated RBC Capital Mkts Sector Perform $222 → $217
Jul-22-16Reiterated RBC Capital Mkts Outperform $220 → $224
Jul-22-16Reiterated FBR Capital Mkt Perform $220 → $170
Jul-18-16Upgrade Jefferies Hold → Buy $210
Jul-08-16Downgrade JP Morgan Overweight → Neutral $196 → $150
May-05-16Reiterated Stifel Buy $209 → $220
May-05-16Reiterated RBC Capital Mkts Sector Perform $209 → $220
Dec-16-15Initiated Credit Suisse Neutral
Nov-09-15Reiterated RBC Capital Mkts Sector Perform $223 → $215
Sep-16-15Initiated JP Morgan Overweight
Sep-08-15Reiterated RBC Capital Mkts Sector Perform $230 → $223
Apr-23-17 01:28AM  Thanks To Democrats, Pre-Existing Conditions Outweigh The Uninsured In The GOP Obamacare Deal Forbes
Apr-21-17 06:08PM  For Knoxville, stakes are high in 'confusing and scary' Obamacare debate CNBC
02:38PM  Acquisition rumors swirl around Kindred Healthcare American City Business Journals
10:03AM  Humana Stock Falls on Downgrade at Jefferies TheStreet.com
Apr-20-17 03:45PM  Humana CEO: Obamacare exit not about politics American City Business Journals
08:30AM  Humana Board Declares Payment of Quarterly Dividend to Stockholders Business Wire
08:15AM  Post Earnings Coverage as UnitedHealth Group Quarterly Revenue Grew 9.4%; Adjusted EPS Soared 31% Accesswire
Apr-19-17 02:55PM  Humana partnering with Ky., Ind., orthopedic groups to improve surgery outcomes American City Business Journals
Apr-18-17 02:44PM  A Tax Day Note To Corporate America: Pay Your Fair Share Forbes
11:00AM  Humana Brings Value-Based Orthopedic Specialty Care to Indiana and Kentucky Business Wire
10:40AM  UnitedHealth 1Q profit soars as ACA business shrinks Associated Press
09:30AM  UnitedHealth's Optum Profits Overcome Obamacare Exit Forbes
Apr-17-17 05:13PM  UnitedHealth Seen as Ready to Weather Obamacare Rewrite TheStreet.com
03:15PM  Humana to Release Detailed First Quarter 2017 Results May 3, 2017; Announces Financial Reporting Segments Realignment Business Wire
02:15AM  Humana requests rate increases for small business HMO, PPO plans American City Business Journals
Apr-16-17 07:53AM  2 Things Obamacare Got Very, Very Wrong Motley Fool
Apr-14-17 03:57PM  Humana teams with tech firm to help certain people with depression American City Business Journals
Apr-13-17 10:00AM  Humana and Happify Health Team Up to Provide Digital Behavioral Health Services to People with Chronic Conditions Business Wire
Apr-11-17 02:59PM  Humana, Inc. : HUM-US: Dividend Analysis : March 31st, 2017 (record date) : By the numbers : April 11, 2017 Capital Cube
Apr-07-17 08:04AM  3 Top Medicare Companies to Buy in 2017 Motley Fool
Apr-06-17 10:20PM  How Humana will be affected by a Medicare payment increase American City Business Journals
12:01PM  Health Carriers Hanging Tough Despite D.C. Debacle Investopedia
Apr-05-17 04:41PM  ObamaCare's Sudden Burst Of Popularity Isn't Going To Last Investor's Business Daily
02:48PM  Deutsche Initiates Coverage On Health Stocks As National Health Insurance Debate Rages On Benzinga
Apr-04-17 11:04AM  Humana Associates Step Together to Achieve Better Health Business Wire
07:50AM  Former Humana exec could get $1.9 million while leaving for new company American City Business Journals
07:25AM  Why Is Humana (HUM) Up 5.2% Since the Last Earnings Report? Zacks
Apr-03-17 06:03PM  U.S. raises Medicare payments to insurers by 0.45 pct in 2018 Reuters
05:01PM  U.S. to raise Medicare payments to insurers 0.45 percent in 2018 Reuters
04:18PM  HUMANA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
03:10PM  Who's really to blame for problems with the health insurance exchanges? at bizjournals.com
03:10PM  Who's really to blame for problems with the health insurance exchanges? American City Business Journals
11:30AM  US stocks turn lower on Wall Street as automakers sink
Apr-02-17 08:29AM  Yes, Obamacare Is Here to Stay -- and Yes, It's Probably Going to Fail Motley Fool
01:10AM  GOP Centrists, Not Freedom Caucus, Are Blocking Deal To Replace Obamacare Forbes
Apr-01-17 04:23PM  ACA Repeal and Replace: Lots of Plans but No Plan B
07:29AM  This Highly Unpopular Change Would Almost Certainly Fix Obamacare at Motley Fool
Mar-31-17 07:35AM  Humana Slowly Reducing 'Unhealthy Days' In Population Health Effort at Forbes
Mar-29-17 04:21PM  Why you can't ignore healthy people in the health insurance debate
01:30PM  Vanderbilt Health Affiliated Network, Humana Enter Value-Based Agreement to Benefit Medicare Advantage Patients Business Wire
Mar-28-17 12:24PM  Humana Stock Trades Ex-Dividend Wednesday at Investopedia
Mar-27-17 08:13AM  Humana, Inc. breached its 50 day moving average in a Bearish Manner : HUM-US : March 27, 2017
Mar-26-17 09:19AM  More States To Expand Medicaid Now That Obamacare Remains Law at Forbes
Mar-24-17 03:03PM  Why Investors Are Piling into the Largest U.S. Health Insurer at The Wall Street Journal
02:11PM  House Reps. Are Predicting Health Care Bill Vote Won't Happen
01:02PM  Today's charts: Investors track health care stocks ahead of vote on new bill
07:20AM  Here are the stocks that win if the Trump-Ryan health-care bill passes, says top analyst at CNBC
06:00AM  Healthcare scramble writes new chapter in Trump's 'Art of the Deal' Reuters
Mar-23-17 11:30PM  White House, House Leaders Put It All on Table For Healthcare Reform
02:58PM  Humana announces progress on massive population health project at bizjournals.com
Mar-22-17 01:10PM  Humana places near top in national customer experience survey at bizjournals.com
11:46AM  Humana 2020 Bold Goal Progress Report: More Healthy Days Achieved, New Programs and Communities Planned Business Wire
11:40AM  Feds probe Humana on false claims to Medicare at bizjournals.com
07:15AM  Health care stocks under GOP plan
Mar-21-17 03:53PM  Health Insurance Lobby Backs Key Trumpcare Revisions at Forbes
03:30PM  ACA Repeal Faces Dire Prognosis
02:15PM  Humana, Continucare Team with Feeding South Florida to Address High Food Insecurity Business Wire
10:48AM  Humana Poised to Grow on Government Business, Strong Capital
Mar-20-17 04:30PM  Humana Inc. to Present at Oppenheimers 27th Annual Healthcare Conference Business Wire
Mar-19-17 09:31AM  U.S. Republicans working on Medicaid, tax credit changes-Ryan Reuters
Mar-18-17 01:00PM  Obamacare Repeal to Cut Deficit, but Greatly Expand Ranks of Uninsured
Mar-17-17 02:35PM  U.S. investigates four insurers over Medicare payments Reuters
01:06PM  U.S. probing insurers beyond UnitedHealth over Medicare charges Reuters
10:09AM  Why Improving Population Health Makes Financial Sense at Forbes
Mar-16-17 05:09PM  HUMANA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation
04:30PM  Humana Completes Aggregate $1.0 Billion of Senior Notes Offering Business Wire
03:37PM  A.M. Best Assigns Issue Credit Ratings to Humana Inc.s Senior Unsecured Notes Business Wire
12:13PM  Obamacare Repeal Takes Another Step but GOP Showdown Looms
Mar-14-17 06:42PM  Trump's New Health Care Frontier
02:57PM  Humana selling bonds to raise $1 billion at bizjournals.com
12:12PM  Health Insurers in Bull Market Territory Despite Iffy American Health Care Act
06:04AM  HUMANA INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Mar-13-17 05:31PM  Humana Prices $1.0 Billion Debt Offering Business Wire
04:17PM  Pro: Hospitals will find themselves in 'very difficult ci...
03:48PM  Humana Is in a Sweet Spot
12:12PM  Humana Inc. -- Moody's rates Humana's senior notes Baa3; outlook stable at Moody's
09:00AM  Humana's Subsidiaries Receive Rating Action from A.M. Best
06:51AM  Street eyes battle for health care control
Mar-10-17 04:30PM  Humana Inc. to Present at the Barclays Global Healthcare Conference Business Wire
10:18AM  House leader: 'very difficult' to speed up end to Medicaid expansion Reuters
08:15AM  Response To GOP Healthcare Bill Ranges From Tepid Support To Outright Opposition
Mar-09-17 12:19PM  Trumpcare Won't Make Health Insurers Sick at The Wall Street Journal
11:09AM  Obamacare Repeal Heads to House Floor After 18 Hours of Debate
Mar-08-17 05:31PM  Humana CEO Bruce Broussard's pay nearly doubled in 2016 at bizjournals.com
04:01PM  A.M. Best Removes From Under Review With Positive Implications and Affirms Credit Ratings of Humana Inc. and Its Subsidiaries Business Wire
01:40PM  Democrats fight Trump-backed U.S. healthcare plan, Ryan defends it Reuters
01:07PM  The Biggest Puzzle About Paul Ryan's ObamaCare Repeal
10:49AM  Health Insurers Hit 52-Week Highs: What's Behind the Rise?
10:00AM  Humana Recognized as Health Care Industry Leader for Corporate Social Responsibility Commitment Business Wire
09:40AM  House panels to launch fight in Congress over Obamacare replacement Reuters
09:25AM  AMA Says Trumpcare Is 'Critically Flawed' at Forbes
Mar-07-17 11:17PM  Stocks: Ready for Trump rally rebound or third straight down day and bigger retreat from Dow 21K? at bizjournals.com
05:50PM  Conservatives rebel against Trump-backed Republican healthcare plan Reuters
05:35PM  Daniel Loeb Buys JPMorgan, Time Warner, Bank of America
05:07PM  3 large-cap buys to play strength in health care: Ross
04:22PM  Stocks Slip Into A Red Finish As RV Makers Break Camp, Data Storage Soars
04:18PM  The Hot Stock: Humana Gains 2.4% at Barrons.com
03:58PM  Biotech beat up?
01:09PM  Today's charts: Aetna, Humana, Cigna and Anthem on the move after new GOP health care bill
11:00AM  Humana and Quartet Team Up to Deliver Integrated Mental Health Care to New Orleans Residents Business Wire
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through three segments: Retail, Group, and Healthcare Services. The Retail segment offers Medicare benefits, as well as commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products directly to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group segment offers commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; and administrative services only products, and health and wellness products to employer groups. It also provides military services, such as TRICARE South Region contract. The Healthcare Services segment offers pharmacy solutions, provider services, home based services, clinical programs, and predictive modeling and informatics services to its health plan members, as well as to third parties. The company also provides closed-block long-term care insurance policies. As of December 31, 2016, it had approximately 14.2 million members in medical benefit plans, as well as approximately 7.0 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BILNEY JODY LSVP & Chief Consumer OfficerMar 21Sale213.804,348929,62013,578Mar 22 01:01 PM
KAY CHRISTOPHER ESVP & Chief Innovation OfficerMar 17Option Exercise0.006,13406,837Mar 21 12:09 PM
MURRAY JAMES EEVP & COOMar 06Option Exercise164.6510,8461,785,74045,635Mar 07 04:06 PM
MURRAY JAMES EEVP & COOMar 06Sale213.6520,3054,338,2300Mar 07 04:06 PM
MURRAY JAMES EEVP & COOMar 06Sale213.5510,8462,316,14834,789Mar 07 04:06 PM
Dunbar Webster RoyDirectorMar 03Sale213.123,000639,3601,166Mar 06 04:55 PM
Zipperle Cynthia HVice President, CAO,ControllerMar 03Sale213.371,885402,2063,736Mar 06 04:48 PM
PETERSON MARISSA TDirectorFeb 27Sale207.523,305685,863761Mar 01 04:18 PM
LeClaire Brian P.SVP & Chief Information Off.Feb 24Option Exercise164.654,971818,45014,258Feb 27 02:53 PM
LeClaire Brian P.SVP & Chief Information Off.Feb 24Sale204.814,9711,018,1029,287Feb 27 02:53 PM
LeClaire Brian P.SVP & Chief Information Off.Feb 22Option Exercise119.7314,6251,751,00537,157Feb 22 07:59 PM
LeClaire Brian P.SVP & Chief Information Off.Feb 22Sale205.2426,8945,519,6179,289Feb 22 07:59 PM
HUNTER CHRISTOPHER H.SVP and Chief Strategy OfficerFeb 22Sale205.204,020824,9208,966Feb 22 06:53 PM
BEVERIDGE, ROY ASr. VP & Chief Medical OfficerFeb 22Sale205.734,832994,0908,931Feb 22 06:47 PM
MURRAY JAMES EEVP & COOFeb 22Sale204.699,5231,949,21659,932Feb 22 09:06 PM
MURRAY JAMES EEVP & COOFeb 21Option Exercise132.1046,1676,098,840115,131Feb 22 09:06 PM
BROUSSARD BRUCE DPresident & CEOFeb 21Option Exercise94.6467,6216,399,648197,316Feb 22 06:43 PM
Zipperle Cynthia HVice President, CAO,ControllerFeb 21Option Exercise44.964,213189,3959,834Feb 22 07:15 PM
MARGULIS HEIDI SSenior V.P. -Corporate AffairsFeb 21Option Exercise102.1697899,90823,589Feb 22 07:18 PM
Huval Timothy S.Senior VP & Chief HR OfficerFeb 21Option Exercise102.165,029513,73742,650Feb 22 07:21 PM
Christopher M TodoroffSr. VP and General CounselFeb 21Option Exercise95.0119,9471,895,18638,978Feb 22 08:09 PM
Christopher M TodoroffSr. VP and General CounselFeb 21Sale205.3324,1404,956,55014,351Feb 22 08:09 PM
BILNEY JODY LSVP & Chief Consumer OfficerFeb 21Sale204.726,0871,246,13817,926Feb 22 08:05 PM
Huval Timothy S.Senior VP & Chief HR OfficerFeb 21Sale204.9425,5295,231,82416,634Feb 22 07:21 PM
MARGULIS HEIDI SSenior V.P. -Corporate AffairsFeb 21Sale205.2813,4522,761,4179,650Feb 22 07:18 PM
Zipperle Cynthia HVice President, CAO,ControllerFeb 21Sale204.674,213862,2835,621Feb 22 07:15 PM
BROUSSARD BRUCE DPresident & CEOFeb 21Sale205.23104,25621,396,77292,086Feb 22 06:43 PM
JONES DAVID A JR/KYDirectorFeb 21Sale205.0427,0005,536,16927,050Feb 23 11:58 AM